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ABSTRACT 
 Prenatal exposure to ethanol can cause serious damage to the developing central 
nervous system.  Among the neurotransmitter systems that are affected by early ethanol 
exposure is the serotonergic system.  In fact, both in vivo and in vitro studies demonstrate 
the vulnerability of the developing serotonergic system to the damaging effects of 
ethanol.  Although ethanol induces apoptotic cell death in these neurons, treatment with a 
serotonin-1A (5-HT1A) agonist prevents the ethanol-associated apoptosis in developing 5-
HT neurons.  One mechanism by which 5-HT1A agonists exert their neuroprotective 
effects appears to involve activation of the phosphatidylinositol 3’kinase (PI-3K) pro-
survival pathway and its downstream activation of NF-κB dependent anti-apoptotic 
genes.  Additional NF-κB dependent genes might also be involved with the 
neuroprotective effects of ipsapirone. 
 There is considerable evidence that ethanol augments apoptosis by increasing the 
levels of reactive oxygen species (ROS).  In light of the neuroprotective effects of 5-HT1A 
agonists and their ability to increase expression of NF-κB dependent genes, it was 
hypothesized that these drugs would also increase the expression of additional NF-κB 
dependent genes that encode specific antioxidant enzymes.  Thus, we investigated the 
effects of ethanol and the 5-HT1A agonist ipsapirone on ROS levels and on the expression 
of genes that encode the antioxidant enzymes Cu/Zn-superoxide dismutase (SOD1), Mn-
superoxide dismutase (SOD2), and catalase.  We also investigated whether ipsapirone 
  xvi 
treatment augments the activity of these enzymes and whether increased activity of these 
antioxidant enzymes reduces ethanol-associated apoptosis (Figure 1).  These studies used 
a fluorescent probe to detect changes in ROS, quantitative real-time RT-PCR to measure 
changes in gene expression, and enzyme assays.  In addition, inhibitors of the 
phosphoinositide-3 kinase (PI-3K) and mitogen-activated protein kinase (MAPK) 
pathways were used to assess the potential involvement of these pathways with the 
effects of ipsapirone. 
 The results of these studies demonstrate that ethanol induces an increase in ROS 
and that ipsapirone pre-treatment prevents this increase.  Time-course studies of the 
expression and enzyme activity of SOD1, SOD2, and catalase showed that ipsapirone 
mediates regulation of these enzymes.  Ethanol treatment resulted in an early and 
transient increase in the expression of the three genes.  However, expression levels 
returned to those in unstressed control neurons after prolonged ethanol exposure.  
Ipsapirone, on the other hand, prevented the latter fall in the expression of the antioxidant 
enzyme genes.  Moreover, addition of EUK-134, which mimics the effects of SOD and 
catalase, attenuates ethanol-associated apoptosis.  Interestingly, inhibitor studies 
suggested that both the PI-3K  Akt and MAPKK  MAPK pro-survival pathways 
might be involved with the effects of ethanol and ipsapirone on the expression of the 
antioxidant genes.  In summary, it appears that some of the neuroprotective effects of 5-
HT1A agonists such as ipsapirone are likely to involve the expression of antioxidant 
enzyme genes.
  17 
CHAPTER 1 
INTRODUCTION 
 
 Alcohol consumption in pregnant women poses a threat to the developing fetus, 
resulting in life-long disabilities that adversely affect the quality of life of the affected 
child.  Fetal Alcohol Spectrum Disorders (FASD) describes the range of effects that 
occur in a child as a consequence of maternal alcohol consumption during pregnancy. 
Fetal Alcohol Syndrome (FAS) presents the most severe form of the disorder.  FAS is 
associated with growth defects, abnormal facial features, and damage to the developing 
central nervous system, which leads to impairment in cognition, learning, memory, 
attention, and behavior (Coffin et al., 2005; Riikonen et al., 2005; Streissguth, 1976; 
Uecker and Nadel, 1998).  The Centers for Disease Control and Prevention (CDC) in the 
United States reported 0.2 to 1.5 cases of FAS for every 1,000 live births.  Without a 
preventative therapeutic treatment, FAS has devastating effects on those affected and 
their families.  It also has a large social impact.   
 Studies in humans show that maternal consumption of alcohol results in 
morphological anomalies in cortical and subcortical regions including the brain stem 
(Bookstein et al., 2001; Clarren et al., 1978; Ferrer and Galofre, 1987; Riikonen et al., 
2005).  In vitro studies indicate that ethanol neurotoxicity is mediated by increased 
apoptosis (Druse et al., 2004; Ramachandran et al., 2003).   Ethanol augments apoptosis
18 
 
by increasing the formation of reactive oxygen species (ROS), which leads to oxidative 
stress.  In fact, there is direct evidence showing that ethanol increases ROS (Novack et 
al., 1982; Thayer and Rubin, 1981) and that accumulation of ROS leads to apoptotic cell 
death (Druse et al., 2005; Druse et al., 2004; Druse et al., 2006; Li et al., 2001a; 
Ramachandran et al., 2003).  Supplemental antioxidant treatment reduces and prevents 
the morphological anomalies and prevents apoptosis that is caused by early ethanol 
exposure (Antonio and Druse, 2008; Chen et al., 2004; Heaton et al., 2004b; Mitchell et 
al., 1999).  
 Human and animal studies show that development of the serotonin system is 
impaired by in utero ethanol exposure (Kim and Druse, 1996b; Rathbun and Druse, 1985; 
Riikonen et al., 2005; Tajuddin and Druse, 1999; Tajuddin et al., 2003).  Serotonin is a 
classical neurotransmitter, which is produced by serotonergic neurons. Serotonin acts 
both as a neurotransmitter and as a neurotrophic factor.  Because the neurotrophic effects 
of serotonin are essential to the normal development of the central nervous system 
(Lauder and Krebs, 1978; Lauder et al., 1985; Mazer et al., 1997; Whitaker-Azmitia et 
al., 1996), ethanol-associated damage to the developing serotonin system affects 
serotonin neurons and other CNS neurons (Eriksen et al., 2002; Kim and Druse, 1996a; 
Sari et al., 2001; Sari and Zhou, 2004; Zhou et al., 2001a; Zhou et al., 2005).   
 Many of the trophic effects of serotonin are mediated by the serotonin-1A (5-HT1A) 
receptor subtype (Druse et al., 2004; Tajuddin and Druse, 1999).  The 5-HT1A receptors 
are found pre-synaptically on the cell bodies of serotonergic neurons and postsynaptically 
on target neurons (Siegel et al., 1999).  Importantly, 5-HT1A receptor activation exerts 
protection against ethanol-mediated (Druse et al., 2005; Druse et al., 2006; Kim and 
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Druse, 1996b; Lee et al., 2009; Tajuddin and Druse, 1999) and hydrogen peroxide-
mediated apoptotic cell death (Lee et al., 2005b; Lee et al., 2001).  The 5-HT1A agonist 
ipsapirone is a well-tolerated anxiolytic drug that is used in the United Kingdom and 
Canada.  Ipsapirone treatment appears to prevent ethanol-induced apoptosis in 
developing 5-HT neurons by activating the phosphatidylinositol 3-kinase (PI-3K)  
pAkt pro-survival pathway and its downstream effects, i.e., augmenting the transcription 
of Nuclear Factor-kappa B (NF-κB) dependent pro-survival genes (e.g. XIAP, Bcl-XL) in 
vitro (Druse et al., 2005; Druse et al., 2006; Lee et al., 2009).  In contrast, a 5-HT1A 
receptor antagonist inhibits ipsapirone-mediated neuronal protection (Druse et al., 2004; 
Druse et al., 2006).   
 In addition to the mentioned pro-survival genes, NF-κB can upregulate other pro-
survival genes and genes that encode the endogenous antioxidant enzymes such as 
Cu/Zn-superoxide dismutase (SOD1), Mn-superoxide dismutase (SOD2), and catalase 
(Pinkus et al., 1996; Rojo et al., 2004; Scandalios, 2005).  These antioxidant enzymes 
maintain redox homeostasis by neutralizing ROS, which are generated during the normal 
cellular respiratory process.  Dysfunction of these enzymes leads to oxidative stress and 
the development of certain neurological disorders.  In contrast, augmenting endogenous 
antioxidants promotes neuroprotection.   
 The research described in this dissertation investigated a potential role for the 5-
HT1A agonist ipsapirone in detoxifying the highly damaging ROS that are generated after 
ethanol exposure.  Specifically, I investigated the effects of ethanol and ipsapirone on the 
levels of ROS and on the expression and activity of the antioxidant enzymes catalase, 
SOD1, and SOD2.  The findings provide new information regarding the potential 
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neuroprotective effects of ipsapirone.  These findings may be relevant to the subsequent 
development of new drugs to prevent brain damage that is caused by prenatal exposure to 
ethanol.   
 
Hypothesis 
 Ipsapirone treatment of ethanol-exposed fetal rhombencephalic neurons increases 
the expression of the genes that encode the antioxidant enzymes Cu/Zn-superoxide 
dismutase (SOD1), Mn-superoxide dismutase (SOD2), and catalase, and the activity of 
these enzymes; increased activity of these antioxidant enzymes reduces ethanol-
associated apoptosis (Figure 1) 
 
Specific Aims 
Specific Aim 1 
 Determine whether ipsapirone prevents accumulation of reactive oxygen species 
(ROS) in ethanol-exposed fetal rhombencephalic neurons. 
 
Rationale  
 Although the mechanism(s) by which ethanol exerts its teratogenic effects are not 
fully understood, several studies show that ethanol can promote the generation and 
accumulation ROS in multiple cell types (Heaton et al., 2002; Novack et al., 1982; 
Ramachandran et al., 2003; Thayer and Rubin, 1981).  The ethanol-associated increase in 
oxidative stress promotes apoptosis.  That supplemental antioxidants can prevent or 
reduce ethanol-triggered toxicity supports the important role of ROS in the teratogenic 
21 
 
Figure 1.  Schematic diagram of the hypothesis and specific aims that was carried 
out in this project.  (A) Aim 1 determined whether ipsapirone prevents accumulation 
of reactive oxygen species (ROS) in ethanol-exposed fetal rhombencephalic neurons.  
(B) Aim 2 demonstrated whether ipsapirone treatment increases the expression of the 
genes encoding the antioxidant enzymes SOD1, SOD2, and catalase in ethanol-
exposed fetal rhombencephalic neurons.  A SOD/catalase mimetic EUK-134 was used 
to determine the effects of the enzymes in preventing ethanol-mediated apoptosis.  (C) 
Aim 3 demonstrated whether the PI-3K pathway is involved with ipsapirone-mediated 
changes in the expression of NF-κB dependent antioxidant enzymes genes that encode 
catalase, SOD1, and SOD2 in ethanol-exposed fetal rhombencephalic neurons. 
22 
 
effects of ethanol (Chen et al., 2004; Heaton et al., 2004b; Li et al., 2001a).  Previous 
work from this laboratory also revealed that treatment with free-radical scavenging 
antioxidants such as EGCG, resveratrol, and lipoic acid reduces the ethanol-associated 
apoptosis (Antonio and Druse, 2008).  There is also evidence that the 5-HT1A agonist 
ipsapirone can prevent ethanol-associated apoptosis (Druse et al., 2004).  In light of the 
common neuroprotective effects of a 5-HT1A agonist and a classical antioxidant, this aim 
will determine whether ipsapirone’s neuroprotective effects might involve an attenuation 
of ethanol-augmented ROS.   Thus, this aim will investigate whether ipsapirone can 
prevent the ethanol-induced generation of ROS. 
 
Design and Methods  
 Because the studies described in this dissertation investigated the effects of ethanol 
and the 5-HT1A receptor agonist on fetal rhombencephalic neurons, the initial studies 
established that the 5-HT1A receptor was expressed in this population of neurons.  
Cultures of fetal rhombencephalic neurons include 5-HT and other developing neurons 
(Druse et al., 2004).  To assess the ethanol-induced generation of ROS two methods, 
fluorescent imaging and fluorescent spectroscopy, were compared using ROS sensitive 
dye 2’,7’-dichlorodihydrofluorescein diacetate (H2DCF-DA).  In order to determine the 
ROS-reducing effects of the 5-HT1A agonist ipsapirone, fetal rhombencephalic neurons 
were treated with ipsapirone either 24 hours prior to the addition of 50 mM ethanol or at 
the time ethanol was added.  The changes in ROS were measured over time by 
fluorescence intensity using a fluorescent microplate reader. 
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Specific Aim 2 
 Determine whether ipsapirone treatment increases the expression of the genes 
encoding the antioxidant enzymes SOD1, SOD2, and catalase in ethanol-exposed fetal 
rhombencephalic neurons. 
 
Rationale 
 Oxidative stress is widely studied as a possible mediator of many neurological 
disorders [Reviewed in (Hamilton et al., 2004; Sun and Sun, 2001; Sun et al., 2001; Wu 
and Cederbaum, 2003)].  With respect to alcohol-related disorders, including FASD, 
ethanol can cause decreased levels of endogenous antioxidants that are involved with the 
neutralization of ROS.  Ethanol can also reduce enzyme activities of three major enzymes 
SOD1, SOD2, and catalase (Heaton et al., 2003a; Heaton et al., 2003b; Ledig et al., 1981; 
Reddy et al., 1999).  However, increasing levels of endogenous antioxidants moderate 
oxidative stress, which results in protective outcomes (Jayalakshmi et al., 2005; Li et al., 
2001a; Liu et al., 2005).  Research shows that overexpression of Sod2 is protective 
against alcohol-induced cellular damage by attenuating the oxidative stress (Wheeler et 
al., 2001).  In addition, catalase increases cell viability in ethanol treated cells (Gonzalez 
et al., 2007; Li et al., 2001a).  Thus, the changes in the expression of SOD1, SOD2, and 
catalase may play a role in moderating oxidative stress and contribute to neuroprotection.  
Interestingly, pharmacological agents such as EUK-134 that mimic SOD/catalase enzyme 
activity also provide protection (Chen et al., 2004; Rong et al., 1999).   
 Previous work from this laboratory demonstrated that the 5-HT1A agonist 
ipsapirone upregulates expression of genes that encode the pro-survival/anti-apoptotic 
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proteins XIAP and Bcl-XL (Druse et al., 2005; Druse et al., 2005; Lee et al., 2009).  These 
and several other pro-survival genes are regulated by transcription factor NF-κB.  
Interestingly, SOD1, SOD2, and catalase are endogenous antioxidant enzymes that 
neutralize naturally occurring ROS, formed during cellular respiration, and their gene 
expression is also regulated by NF-κB (Pinkus et al., 1996; Rojo et al., 2004; Scandalios, 
2005).   
 Because ipsapirone provides neuroprotection against ethanol-associated apoptosis 
and because this drug augments the expression of at least two NF-κB dependent pro-
survival genes, ipsapirone might also increase the expression of additional NF-κB 
dependent genes, i.e., those encoding endogenous antioxidant enzymes. This aim studied 
the effects of ipsapirone on the regulation of gene expression and enzyme activities of the 
antioxidant enzymes SOD1, SOD2, and catalase in control and ethanol-exposed fetal 
rhombencephalic neurons.  In addition, the potential neuroprotective effects of 
pharmacological SOD/catalase mimicry were assessed.   
 
Design and Methods  
 Cultured fetal rhombencephalic neurons were studied in four treatment groups: 
Control (no ethanol/no ipsapirone), Ipsapirone (no ethanol/ 100 nM ipsapirone), Ethanol 
(50 mM ethanol/ no ipsapirone), and Ethanol + Ipsapirone (50 mM ethanol/ 100 nM 
ipsapirone).  Since the protective effects of ipsapirone on ethanol-induced apoptosis, i.e. 
reduction in apoptosis and elevation of pro-survival gene expression, occurred within 24 
hours (Druse et al., 2004; Druse et al., 2006), temporal expression profiles of the 
endogenous antioxidants enzymes were determined to better understand the roles of these 
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enzymes.  Real-time RT-PCR was performed to determine the changes in mRNA after 
the treatments at various times. 
 To assess the potential importance of SOD and catalase in ethanol-induced 
apoptosis, neurons maintained in the presence of 0 or 50 mM ethanol were co-treated for 
24 hours with EUK-134, a pharmacological SOD/catalase mimetic.  To determine the 
optimal dose, two concentrations of EUK-134 were used, i.e., 0.5 µM and 5 µM.  As 
previously employed (Antonio and Druse, 2008; Druse et al., 2004), Hoechst 33342 
staining was used to detect and to compare apoptotic nuclei (condensed or fragmented) in 
these treatments. 
 
Specific Aim 3 
 Determine whether the PI-3K pathway is involved with ipsapirone-mediated 
changes in the expression of NF-κB dependent antioxidant enzymes genes that encode 
catalase, SOD1, and SOD2 in ethanol-exposed fetal rhombencephalic neurons. 
 
Rationale 
 The pro-survival effects that are mediated by 5-HT1A receptors potentially involve 
several well-known signaling pathways (Abdouh et al., 2004; Adayev et al., 1999; 
Adayev et al., 2003; Hsiung et al., 2005).  One of these pathways involves activation of 
PI-3K  pAkt and subsequent downstream activation of transcription factor NF-κB 
(Abdouh et al., 2004; Cowen et al., 1997; Dhandapani et al., 2005).  Previous work from 
this laboratory revealed that the 5-HT1A agonist ipsapirone activates PI-3K  pAkt in 
cultures of ethanol treated fetal neurons (Druse et al., 2005).  Additional studies indicate 
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that MAPK signaling pathways and crosstalk between other pathways may also be 
involved with 5-HT1A receptor-mediated protection (Adayev et al., 1999; Adayev et al., 
2003).  Activation of these pro-survival signaling pathways leads to upregulation of 
genes that encode proteins that promote cell survival.  That is, activation of PI-3K  
pAkt by ipsapirone upregulates the expression of XIAP and Bcl-XL in ethanol-exposed 
fetal rhombencephalic neurons (Druse et al., 2006; Lee et al., 2009).  Therefore, this aim 
investigated pathways that might be involved in the activation of the NF-κB dependent 
antioxidant enzyme genes that encode SOD1, SOD2, and catalase.   
 
Design and Methods  
 To investigate which signaling pathways might be involved with ipsapirone’s 
effects on fetal rhombencephalic neurons, the PI-3K inhibitor LY294002 and the MAPK 
inhibitor PD98059 were included in studies in which cells neurons were cultured in the 
presence of 0 or 50 mM ethanol and/or 0 or 100 nM ipsapirone.  As described in Aim 2, 
real-time RT-PCR was used to assess the changes in mRNA.  Appropriate time points 
were determined on the basis of the results from Aim 2.  That is, inhibitor studies were 
performed at a time when increased gene expression was observed.
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
 
Fetal Alcohol Syndrome 
 
In the early 1900s, Europeans reported an association between chronic maternal 
alcohol consumption and infant mortality (Sullivan, 1900).  In 1973, Jones and 
colleagues (Jones and Smith, 1973) described the teratogenic effects of ethanol in the 
United States.  The extensive abnormalities in children with Fetal Alcohol Syndrome 
(FAS) included growth deficiency, limb and joint abnormalities, craniofacial 
abnormalities, and fine motor skill dysfunction (Hanson et al., 1976; Jones and Smith, 
1975). Many studies over the subsequent three decades confirmed and extended the 
original findings.  They demonstrated that alcohol ingestion during gestation causes 
severe abnormalities in FAS offspring (Darby et al., 1981; Naidoo et al., 2006; Smith, 
1981; Sowell et al., 2002a).  In recent years, there has been considerable effort devoted to 
further elucidating the effects of ethanol on the developing fetus and investigating the 
mechanisms that underlie the toxic effects of ethanol. 
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FAS and FASD nomenclature In the past, the term FAS was widely used to describe many of the disorders found in children whose mothers ingested alcohol during pregnancy.  In a recent effort to provide more clarity, Hoymes et al. (Hoyme et al., 2005) described the spectrum of disorders associated with maternal alcohol consumption as Fetal Alcohol Spectrum Disorders (FASD).  The term FASD includes FAS and other alcohol‐related developmental disorders.  
 
Diagnosis of FAS and FASD  
In early studies of humans, participants were usually screened for FAS based on a 
history of maternal alcoholism and the presence of additional characteristics, including 
growth deficiency, certain craniofacial characteristics, and noticeable physical anomalies 
(small head, limb malformation, etc) (Darby et al., 1981; Hanson et al., 1976; Hayden 
and Nelson, 1978).  Even then, researchers knew that differences in drinking patterns of 
the mothers (chronic or occasional drinkers, heavy or moderate drinkers) contributed to 
differences in the severity of alcohol-related deficits in their children [reviewed in 
(Streissguth et al., 1980)]. 
In light of well recognized difficulties in identifying FAS and FASD [reviewed in 
(Sampson et al., 1997)], The Institute of Medicine (IOM) issued a guideline for 
diagnosing FAS and other alcohol-related effects (IOM-Institute of Medicine (U.S.). 
Division of Biobehavioral Sciences and Mental Disorders. Committee to Study Fetal 
Alcohol Syndrome., 1996). The recently revised diagnostic criteria (Figure 2) assigned 
those affected with FASD to one of six classifications: 1) FAS with confirmed maternal 
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alcohol exposure, 2) FAS without confirmed maternal alcohol exposure, 3) partial FAS 
with confirmed maternal alcohol exposure, 4) partial FAS without confirmed maternal 
alcohol exposure, 5) Alcohol Related Birth Defects (ARBD), and 6) Alcohol Related  
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Figure 2.  A guideline for diagnosing FAS and other alcohol-related effects.  
The Institute of Medicine (IOM) issued a guideline for diagnosing FAS and other 
alcohol-related effects.  This is an updated version of the guideline published by 
Hoyme and colleagues (Hoyme et al., 2005) 
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Neurodevelopmental Disorder (ARND) (Hoyme et al., 2005).  For example, FAS with 
confirmed maternal alcohol exposure presents the most severe diagnosis in which all of 
the following criteria must be met.  This assignment requires confirmed maternal alcohol 
exposure, evidence of a characteristic pattern of minor facial anomalies (short palpebral 
fissures, thin vermilion border of the upper lip, smooth philtrum), evidence of prenatal 
and/or postnatal growth retardation (height or weight less than the10th percentile, 
corrected for racial norms, if possible), and evidence of deficient brain growth or 
abnormal morphogenesis (structural brain abnormalities, head circumference less than 
10th percentile).   
 
Human Studies of FAS 
 
The Development of Multiple Organ Systems: Effects of In Utero Ethanol Exposure 
 Many of the early studies of humans with FAS focused on specific clinical cases 
and the description of patients’ congenital anomalies, including growth deficiencies as 
well as limb and craniofacial malformations (Castells et al., 1981; Hanson et al., 1976; 
Jones et al., 1974; Jones et al., 1976).  These abnormalities are visible indications that are 
still included in the guidelines of FASD diagnosis (see Diagnosis).  In addition to the 
visible abnormalities in ethanol-exposed children, there is evidence that several 
developing organs are vulnerable to ethanol toxicity.  An early study revealed that cardiac 
malformations, including interruption in the aortic arch and ventricular septal defects, 
were found in some infants with FAS (Steeg and Woolf, 1979; Terrapon et al., 1977).  
There is also evidence of abnormal development of the kidney (Qazi et al., 1979), 
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skeleton (van Rensburg, 1981), ocular system (Stromland and Sundelin, 1996), and brain 
(Clarren et al., 1978) in FAS children. Thus, alcohol consumption during pregnancy has 
the potential to adversely affect many aspects of development and to cause lasting 
damage that is detected in infancy, childhood, and adulthood.  Although only a small 
number of children affected by FAS have died, the limited number of postmortem 
autopsies confirmed the toxic effects of ethanol on developing brain (Clarren et al., 1978; 
Jones and Smith, 1975).   
The following sections review the effects of ethanol on the development of CNS. 
 
The Development of the Central Nervous System: Effects In Utero Ethanol Exposure 
Prenatal alcohol exposure is particularly harmful to the developing central 
nervous system (CNS).  In fact, damage to the developing CNS has been a major focus of 
FAS research because of the extent of ethanol-associated CNS injury and its long-term 
functional consequences.  Prenatal alcohol exposure is particularly injurious to the 
developing CNS (Hanson et al., 1976; Kennedy, 1984), because it is one of the earliest 
organ systems to develop.  Also, CNS development is prolonged and the brain is 
vulnerable to the damaging effects of ethanol throughout most of gestation.  
 
Neuropathological Studies and Brain Morphology: Effects of In Utero Ethanol Exposure 
Early clinical cases and postmortem brain analyses of FAS were reported by 
research groups from Europe and the United States (Jones and Smith, 1973; Lemoine et 
al., 1968; Sullivan, 1900).  Studies from the 1970’s and 1980’s described the brain 
dysmorphology that is associated with FAS and FASD.  A report by Clarren and 
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colleagues focused on neuropathological observations from four children and the 
associated drinking habits of their mothers (Clarren et al., 1978).  In two cases, brain 
malformations positively correlated with the mothers’ self-reported drinking habits: the 
more alcohol the mother drank, the greater the brain malformations in the child.  
Additional brain abnormalities were consistent with earlier reports (Hanson et al., 1976; 
Jones and Smith, 1975).  Clarren’s report also showed that the brains of affected children 
were highly disorganized, due to errors in the migration of neurons and glia (Clarren et 
al., 1978; Jones and Smith, 1975).  Other offspring of chronic alcoholic mothers 
exhibited dysmorphology of dendritic spines, suggesting dysfunction of the neurons 
(Ferrer and Galofre, 1987) and microcephaly.  In the latter case, severe midline cerebral 
malformations were present, including a partially fused frontal lobe and the absence of 
olfactory bulbs and tract, pituitary lobe and anterior corpus callosum (Coulter et al., 
1993).  Roebuck and colleagues provided a thorough review of brain dysmorphogenesis 
in FAS children (Roebuck et al., 1998).  Taken together there is evidence of substantial 
and diffuse pathological brain damage in FAS. 
 
Neuropsychological Studies Detect Abnormalities in Fetal Alcohol Offspring 
As more pathological cases describing brain dysmorphology were reported, many 
researchers became interested in the functional consequences of the brain abnormalities. 
The results of their studies show that there are neurobehavioral changes in children 
exposed to ethanol in utero (Slavney and Grau, 1978; Streissguth, 1976; Streissguth, 
1977; Streissguth et al., 1994; Yellin, 1984). The adverse effects of alcohol on the 
developing brain are manifested in neuropsychological impairments (Aronson et al., 
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1985; Steinhausen et al., 1982; Streissguth, 1976) that include attention deficits (Riikonen 
et al., 2005), learning difficulties (Coffin et al., 2005), memory impairment (Uecker and 
Nadel, 1998), and abnormal motor development (Olson et al., 1998).  FAS and FASD 
children showed characteristics of attention deficits that are distinct from those in ADHD 
children, particularly when tested with an eyeblink conditioning test (Coffin et al., 2005).  
A deficit in CNS-controlled motor skills and coordination were found in 75% of FASD 
patients (Connor et al., 2006).  Interestingly, some of the neuropsychological deficits are 
still found in adulthood (Barr et al., 2006; Malisza et al., 2005; Streissguth et al., 1991).  
As evidence of cognitive abnormalities, children with FAS have impaired spatial 
working memory (Uecker and Nadel, 1998), which did not improve with age (Malisza et 
al., 2005).  Also, children with FAS performed poorly on auditory and visual attention 
tests (Connor et al., 1999), but object memory seemed to be spared (Uecker and Nadel, 
1998). Verbal learning deficits, including abnormalities encoding verbal information 
have been described, too (Mattson et al., 1996).  Generally, low IQ scores were found in 
FASD children, but these abnormalities were not sufficient to completely explain 
attention and memory deficits (Olson et al., 1998).  Irrespective of IQ scores, all FASD 
children (those having low and normal IQ scores) performed poorly on complex 
attention, verbal learning, and executive function tests (Kerns et al., 1997). 
In addition, to learning deficits and attention abnormalities, many young adults 
with FASD exhibit psychiatric disorders.  Neuro-psychological disorders related to 
prenatal exposure to alcohol include attention deficit, depression, and anxiety disorders.  
The latter conclusion was based on the responses of FASD offspring to chronic mild 
stress and on subsequent changes in stress hormones (Hellemans et al., 2008).  In 
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addition, prenatal exposure to alcohol significantly increases the probability of 
developing substance abuse/dependence as well as somatoform, paranoid and passive-
aggressive traits (Barr et al., 2006). 
 
Neuro-imaging Studies: Brain Dysmorphology and Functional Abnormalities 
 In several studies, sophisticated neuro-imaging methods were used to provide 
more detailed information regarding the neuroanatomical changes in FASD children.  
Undoubtedly, many of these changes are functionally related to neuropsychological 
conditions in FAS.  For example, when FASD children were given response-inhibition 
tasks and evaluated for attention, the functionally active brain regions in the alcohol-
exposed children were different from those in controls.  MRI studies showed that the 
prefrontal cortical regions were more highly activated in FASD children and the right 
caudate nucleus was less activated (Fryer et al., 2007).  MRI studies also showed that the 
hippocampus, a brain region that is involved with learning and memory, had 
asymmetrical development in FASD children.  That is, the left hemisphere hippocampus 
(compared to right hemisphere) had a disproportionately smaller volume and received a 
reduced blood supply (Riikonen et al., 1999).  A reduced volume of the basal ganglia was 
also found (Archibald et al., 2001).  In addition, it should be noted that motor function 
impairment is found in FAS, and 75% of FASD children demonstrated a reduced size of 
the cerebellum (Bookstein et al., 2006).  Moreover, MRI studies consistently found a 
reduction of brain gray and white matter (Archibald et al., 2001; Gabrielli et al., 1990; 
Sowell et al., 2002b).  One study demonstrated lateral splenial/parietal white matter 
abnormalities, which could correlate with poor visuomotor integration (Sowell et al., 
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2008).  While integration of information plays an important role in cognition, 
abnormalities in the corpus callosum (Bookstein et al., 2001; Bookstein et al., 2002; 
Bookstein et al., 2002; Riley et al., 1995; Sowell et al., 2001) are among the most 
prominent findings in studies of FASD children.  Imaging techniques facilitated the 
measurement in the changes of specific neurotransmitter systems.  In fact, Riikonen et al. 
reported that the serotonin system seems to be vulnerable to prenatal exposure to ethanol 
as shown by a reduction of serotonin content in cortical regions (Riikonen et al., 2005).  
Additional animal studies, demonstrating ethanol-associated abnormalities in the 
developing serotonin system are reviewed in a subsequent section. 
 
Critical/Vulnerable Periods of CNS Development: Effects of In Utero Ethanol Exposure 
 Defining the critical/vulnerable periods for teratogenic effects of alcohol continues 
to be an important topic in the field fetal alcohol research (Kalmus and Buckenmaier, 
1989; Sulik et al., 1981; Yelin et al., 2007).  Such studies show that fetal exposure to 
ethanol negatively affects embryogenesis (Sulik K.K, 2008) as well as fetal development 
(Smith, 1980).  One study showed that maternal administration of ethanol during the 
preimplantation period causes severe developmental abnormalities in embryos 
(Padmanabhan and Hameed, 1988).  In addition, ethanol administration during 
gastrulation results in craniofacial dysmorphogenesis (Sulik and Johnston, 1983).  Early 
ethanol exposure also prevents the normal closing of neural tube, which can lead to 
neural tube defects like dysraphia and anencephaly (Chen et al., 2005).  It is not 
surprising that embryos are particularly susceptible to ethanol because they do not have a 
functional placenta or liver to properly metabolize ethanol.  However, ethanol also exerts 
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teratogenic effects when it is administered later in gestation.  In fact, neuronal cells in 
different regions of developing brain were vulnerable when ethanol exposure (Druse and 
Paul, 1988; West, 1993) was confined to the second and third trimesters,    
 
Animal Models of Fetal Alcohol Syndrome Disorder 
 
Importance of Animal Models in the Study of FAS and FASD 
 The development of animal models of FAS provides a means by which some of 
the limitations of human studies can be avoided.  For example, the frequent consumption 
of additional drugs of abuse by mothers of FAS children (Weiner et al., 1983) 
complicates our understanding of the effects of ethanol on development.  However, 
investigators can readily control the dose, duration of treatment, and other variables in 
animal studies.  Fortunately, observations made using animal models seem to correspond 
well with human studies [reviewed in (Driscoll et al., 1990)].   
Several in vivo findings in human and animals studies parallel each other, 
especially with regard to the neuroanatomical and neurobehavioral effects of ethanol.  
Both human studies (See Human Studies of FASD) and animal studies demonstrated 
diffuse effects of alcohol on the developing brain (He et al., 2005; Herrera et al., 2003; 
Stoltenburg-Didinger and Spohr, 1983; West et al., 2001).  Both humans and rats exposed 
to ethanol early in development demonstrate evidence of a functional impairment of the 
cerebellum, abnormal cerebellar development (Brown et al., 2008; Coffin et al., 2005; 
Maier et al., 1999), and reduced cerebellar size (Bookstein et al., 2006) and/or cell 
number (Maier et al., 1999).  In addition, FASD children exhibit impaired eyeblink 
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behavior, which is indicative of cerebellar abnormalities (Coffin et al., 2005; Jacobson et 
al., 2008).  Rats, exposed to ethanol early in development, also demonstrate impairment 
of a similar behavior (Brown et al., 2008).  Using in vitro studies of the cerebellum, 
several laboratories proposed possible mechanisms for the ethanol-mediated cerebellar 
abnormalities (Heaton et al., 2004a; Luo et al., 1997; Ramanathan et al., 1996).  It is clear 
that both in vivo and in vitro animal studies, provide important information regarding 
possible mechanisms that contribute to CNS damage in FASD.  
  Additional examples of parallels between human and rodent studies come from 
investigations of spatial memory and studies of the hippocampus.  For example, ethanol-
exposed rats require a longer time to learn the Morris water maze task, which assesses 
spatial short term memory (Clements et al., 2005).  Spatial memory abnormalities did not 
improve with age in humans (Malisza et al., 2005).  In the hippocampus, both reduced 
neurogenesis (Clements et al., 2005; He et al., 2005) and increased apoptosis were 
detected (Wozniak et al., 2004).  Also, human MRI studies showed that the left 
hemisphere hippocampus had a disproportionately smaller volume and received a 
reduced blood supply (Riikonen et al., 1999). The noted changes could contribute to 
functional and behavioral anomalies.   
 The development of several neurotransmitter systems, including those containing 
dopamine, GABA, serotonin, acetylcholine, noradrenaline, and glutamate (Druse et al., 
1990; Druse et al., 1991; Mooney and Miller, 2001; Riley et al., 2001; Smith, 1979; 
Tajuddin and Druse, 1999; Tajuddin and Druse, 2001) are adversely affected by in utero 
ethanol exposure.  The effects of ethanol on the development of the serotonin system is of 
39 
 
particular relevance to this dissertation research.  Those studies are described in a later 
section. 
 
In vivo and In Vitro Animal Studies: Ethanol Promotes Apoptosis 
 Several studies show that ethanol augments the apoptosis in developing neurons 
(Druse et al., 2004; Heaton et al., 2004b; Jacobs and Miller, 2001; Li et al., 2001b; Olney 
et al., 2002b; Ramachandran et al., 2003).  Apoptosis is a programmed cell death that 
involves receptor-mediated (extrinsic) or mitochondria-mediated (intrinsic) pathways.  
Both pathways ultimately lead to the fragmentation of DNA, which is facilitated by the 
executioner caspase-3 [reviewed in (Ryter et al., 2007)].  Ethanol can promote apoptosis 
by activating either the extrinsic or intrinsic pathway.  Along with the visible evidence of 
apoptotic neurons mentioned above, in vivo and in vitro treatment with ethanol activates 
caspase-3 (Jacobs and Miller, 2001; Mooney and Miller, 2001; Olney et al., 2002a) 
(Mooney and Miller, 2001) and increases the expression of genes encoding the pro-
apoptotic members of the Bcl-2 family, e.g, Bax and Bcl-XS (Mooney and Miller, 2001; 
Moore et al., 1999).  Also, in vitro ethanol exposure induces DNA laddering, which is 
indicative of DNA fragmentation and apoptosis (Oberdoerster et al., 1998).  
It appears that the ethanol-mediated toxicity might be linked to activation of pro-
apoptotic pathways and/or inhibition of pro-survival signaling pathways.  For example, 
ethanol inhibits a neurotrophic effect by blocking the increase in intracellular Ca2+ that is 
mediated by activation of the N-methly-D-aspartate (NMDA) glutamate receptor subtype 
(Bhave and Hoffman, 1997).  In addition, ethanol inhibits the PI-3K pro-survival 
pathway that is activated by insulin-like growth factor 1 (IGF-1).  This inhibition results 
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in apoptosis of cerebellar granule neurons (Zhang et al., 1998).  Ethanol also promotes 
apoptosis in primary cultures of developing serotonergic neurons, presumably by 
reducing the activation of the PI-3K pro-survival pathway (Druse et al., 2005). 
 
In Vitro Animal Studies: The mechanisms of Ethanol Toxicity 
It can be difficult to use in vivo animal models of FASD because it is difficult to 
get rats to consume high quantities of ethanol.  In vitro models facilitate use of a 
controlled treatment; this is useful for assessing specific mechanistic changes, e.g., gene 
expression, cell signaling, post-translational protein modifications, and DNA damage.  As 
noted previously, potential explanations for the damaging effects of ethanol on the 
developing hippocampus come from in vitro studies done by several researchers.  Using 
in vitro models of ethanol exposure, it was suggested that the abnormal cerebellar 
development might be explained by at least three factors: ethanol’s inhibition of L1-
mediated cell adhesion of cerebellar granule cells (Ramanathan et al., 1996); lack of 
essential neurotrophic factors (Luo et al., 1997); and/or the presence of oxidative stress 
(Heaton et al., 2004a).   
In vitro research is also helpful in studies of potential therapeutic agents.  For 
example, in vitro studies showed that the protective effects of the 5-HT1A agonist 
ipsapirone against ethanol-induced apoptosis in developing neurons was mediated in part 
by stimulation of pro-survival signaling pathways (Druse et al., 2005).  In addition, there 
is in vitro and/or in vivo evidence from this and other laboratories that antioxidants 
(Antonio and Druse, 2008; Chen et al., 2004; Heaton et al., 2004b; Siler-Marsiglio et al., 
2004) as well as specific neuropeptides (Arevalo et al., 2008; Chen et al., 2005; Parnell et 
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al., 2007) provide neuroprotection from the damaging effects of ethanol on the 
developing CNS. 
Taken together, both in vivo and in vitro animal studies not only supplement 
findings in human FASD, but also are useful to elucidate the mechanisms underlying the 
toxic effects of ethanol and to identify potential neuroprotective agents. 
 
THE SEROTONIN SYSTEM 
 
Serotonin (5-hydroxytryptamine or 5-HT) is a monoamine neurotransmitter 
(Figure 3) that is synthesized from tryptophan.  In brain, a large population of 
serotonergic cell bodies is located in groups in the raphe nuclei.  Surprisingly, 5-HT was 
initially not recognized as a neurotransmitter.  A review by Whitaker-Azmitia discusses 
the history of research on 5-HT. 1) 5-HT was first discovered in chemicals isolated from 
smooth muscle of the gut.  2) Drs. Twarog and Page first showed the existence of 5-HT 
in mammalian brain in 1953 (Whitaker-Azmitia, 1999).  Since the early discoveries, 
many studies have shown important behavioral effects of 5-HT.  That numerous drugs 
that act on the 5-HT system are used to treat anxiety, stress and depression emphasizes 
the involvement of this CNS neurotransmitter with these behaviors. 
 
Development of Serotonin System: 5-HT as a Neurotrophic Factor 
Following the discovery that neuronal cell bodies in brain stem produced 
monoamines (Dahlstroem and Fuxe, 1964), the 5-HT cell bodies (raphe nuclei) and their 
projections were described in prenatal rat brain (Olson and Seiger, 1972).  In the  
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Figure 3.  Chemical structure of serotonin.  Serotonin, also known as 5-
hydroxytryptamine (5-HT), is a monoamine neurotransmitter that contains an 
indole ring as a backbone structure.  It is derived from the precursor amino acid 
tryptophan. 
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developing rat CNS, 5-HT neurons are first detected around gestation day 12 (G12), 
where G=0 corresponds to the day of insemination.  (Aitken and Tork, 1988; Lauder and 
Bloom, 1974; Wallace and Lauder, 1983), and their differentiation peaks between G15 
and G16 (Lauder and Krebs, 1978).  Ascending projections of 5-HT neurons are detected 
by G12  (Aitken and Tork, 1988; Lidov and Molliver, 1982a; Wallace and Lauder, 1983) 
and they continue to develop until the third postnatal week.  By G19 the distribution of 5-
HT neurons in the fetal rat brain resembles that of the adult (Lidov and Molliver, 1982b; 
Wallace and Lauder, 1983).   
The very early development of the 5-HT system suggested the possibility that 5-
HT might also influence CNS development.  In support of this neurotrophic role of 5-HT, 
the Lauder laboratory described several adverse developmental effects that occurred 
when in vivo 5-HT synthesis was inhibited during critical period of 5-HT development by 
the tryptophan hydroxylase inhibitor pCPA.  This treatment led to a depletion of 5-HT 
(Lauder et al., 1985) and delayed differentiation of  target cells, i.e., those that receive 
afferent signals from serotonergic neurons (Lauder and Krebs, 1978).  5-HT depletion 
during synaptogenesis gave rise to decreased synaptic density in the hippocampus, which 
led to learning deficits (Mazer et al., 1997).  A comprehensive review by Whitaker-
Azmitia et al. describes the role of 5-HT as an essential neurotrophic factor for normal 
CNS development and discusses the effects of additional factors on the development of 
the 5-HT system (Whitaker-Azmitia et al., 1996).  In developing rodent brains, the 5-
HT1A receptor is also involved with the migration cranial neural crest cells (Moiseiwitsch 
and Lauder, 1995).  Because 5-HT exerts neurotrophic effects on its own and other CNS 
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neurons, any damage to 5-HT system can have significant adverse effects on the 
development of CNS.   
 
The Developing Serotonin System: Sensitivity to Ethanol 
In addition to the widespread teratogenic effects of ethanol that have been 
mentioned, studies from this and another laboratory show that ethanol prevents normal 
development of 5-HT system (Figure 4).  Chronic exposure to a 6.6% (v/v) ethanol, 
through maternal consumption of a liquid diet during gestation damaged the developing 
5-HT system.  Ethanol-associated abnormalities include: 1) significantly decreased 
concentration of 5-HT and/or the 5-HT metabolite 5-hydroxyindoleacetic acid in the 
cortex, cerebellum, and brain stem (Rathbun and Druse, 1985); 2) reduced density of 5-
HT reuptake sites and altered density of 5-HT1A receptors (Druse and Paul, 1988; Kim 
and Druse, 1996b; Tajuddin and Druse, 1988); and 3) fewer 5-HT immunopositive 
neurons in the raphe region (Tajuddin and Druse, 1999).  In vitro studies, such as those 
described in this dissertation, demonstrated that a 24-hour treatment of ethanol promotes 
apoptosis in cultures of fetal 5-HT and other rhombencephalic neurons (Druse et al., 
2004).  Additional studies revealed that the mechanism underlying the adverse effects of 
early ethanol exposure might involve reduced activity of the PI-3KpAkt, pro-survival 
signaling pathway (Druse et al., 2005; Druse et al., 2004), and the decreased expression 
of NF-κB pro-survival genes including Bcl-2, Bcl-XL, Xiap, Ciap1, and Ciap2 (Druse et 
al., 2006).  Additional work from another laboratory confirmed the sensitivity of the 
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developing 5-HT system to the adverse effects of ethanol (Sari et al., 2001; Zhou et al., 
2001a).   
 
Protective Effects of a 5-HT1A Agonist Against Ethanol Toxicity 
Maternal treatment with a 5-HT1A agonist during the period of the peak 5-HT 
neuronal development, i.e, G13 to G20, prevented the ethanol-associated decrease in 5-
HT reuptake sites (Kim and Druse, 1996b) and the altered density of 5-HT1A receptors 
(Kim et al., 1997) in the terminal regions.  Most importantly, when ipsapirone, the 5-
HT1A agonist used in this dissertation research, was administered during the same in 
utero period, this treatment prevented the ethanol-associated reduction of 5-HT neurons 
and of astrocytes in the raphe region of developing rat brain (Tajuddin and Druse, 1999; 
Tajuddin and Druse, 2001; Tajuddin et al., 2003).  Recent in vitro studies revealed that 
ipsapirone could also prevent the ethanol-associated increase in apoptotic 5-HT and other 
rhombencephalic neurons (Druse et al., 2004).  Further in vitro studies showed that 
ipsapirone’s protective effects might involve its ability to prevent the ethanol-associated 
decrease in PI-3KpAkt pro-survival signaling (Druse et al., 2005).  In vitro studies also 
found that a 24-hour co-treatment with ipsapirone was able to increase expression of NF-
κB dependent genes that encode the pro-survival proteins XIAP and Bcl-XL in fetal 
rhombencephalic neurons (Druse et al., 2006).  Activation of additional NF-κB 
dependent genes that encode pro-survival proteins or antioxidant enzymes could also 
provide neuroprotection against ethanol.  The established and potential neuroprotective 
effects of ipsapirone could be important clinically, because this anxiolytic drug lacks the 
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side-effects associated other 5-HT1A agonists currently prescribed (Feighner and Boyer, 
1989). 
 
5-HT1A Receptor-Mediated Signaling Pathways 
Development of the 5-HT1A receptors begins during gestation in rodents. 
Expression of the gene encoding the 5-HT1A receptor is detected by G14.5 in several 
regions of the developing brain and is maintained throughout the development of most of 
those areas (Bonnin et al., 2006). There is also an in utero peak in the density of 5-HT1A 
receptors, which occurs at G15-16 (Hillion et al., 1993).  This coincides with the peak 
differentiation period for 5-HT neurons.   
Like other members of the 5-HT1 receptor family, the 5-HT1A receptor is 
negatively coupled to adenylyl cyclase via Gi/o proteins.  It is also involved in the opening 
of K+ channels, which leads to neuronal hyperpolarization (Raymond et al., 1999; Siegel 
et al., 1999).  Besides its classic role, the 5-HT1A receptor has been linked to signaling 
pathways, including those involved with protein kinase Cα, mitogen activated protein 
kinase (MAPK), and PI-3KpAkt, and NF-κB (Abdouh et al., 2004; Adayev et al., 
1999; Adayev et al., 2003; Cowen et al., 1997; Hsiung et al., 2005).  Importantly, the 
mentioned signaling pathways are known to promote cell survival.  The link of specific 
pathways to the 5-HT1A receptor appears to be cell-specific.   
 
5-HT1A-Mediated Protective Effects 
Many studies demonstrated that treatment with 5-HT1A agonists provides 
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Figure 4.  Prenatal ethanol exposure damages developing raphe nuclei.  Raphe 
nuclei contain cell bodies of neurons that produce 5-HT, which exerts neurotrophic 
effects during the CNS development.  Therefore, damage to raphe nuclei, 
particularly to serotonergic neurons, can lead to abnormal development of the 
target regions of the developing brain, including the hippocampus, cerebellum, and 
cortex. 
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neuroprotection from ischemic damage to neurons (Bielenberg and Burkhardt, 1990; 
Bode-Greuel et al., 1990; Prehn et al., 1993; Ramos et al., 2004).  It also prevented 
staurosporine-induced apoptosis of hippocampal and cortical cells (Suchanek et al., 
1998).  In one of the most intriguing studies with regard to this dissertation research, a 5-
HT1A agonist inhibited hydrogen peroxide-induced oxidative stress and neuronal death in 
developing cortical neurons (Lee et al., 2005b).  In addition, protective effects of some 
other agents seemed to be mediated by the expression of 5-HT1A receptors (Xu et al., 
2007).  
 
Potential Mechanisms of Ethanol Toxicity in Developing CNS 
 
It is clear that alcohol damage to the developing brain and other organs is 
extensive.  Functional signs of brain damage are found in FASD-associated 
neuropsychological and neurobehavioral disorders.  There are intrinsic difficulties 
associated with studying the mechanisms of FASD in humans, because of differences in 
clinical, socio-economical, and genetic status of mothers as well as in amount, duration, 
and timing of alcohol exposure (Goodlett et al., 2005).  However, several in vitro and in 
vivo animal studies provide information regarding the mechanisms that underlie the 
ethanol-associated damage.  One of these mechanisms involves oxidative stress.  In 
addition, the effects of acetaldehyde, a reactive metabolite of ethanol, cannot be ignored.   
In a subsequent section, the evidence that ethanol-associated toxicity can be 
caused by oxidative stress is reviewed.  Later sections also review the metabolism of 
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ethanol, its effects on the mitochondrial electron transport chain (ETC), and generation of 
oxidative stress that are most relevant to the current dissertation. 
 
Damaging Effects of Oxidative Stress 
Levels of ROS, produced in normal physiological conditions, are managed by 
endogenous antioxidants and antioxidant enzymes.  The endogenous antioxidants include 
glutathione (GSH) and several antioxidant enzymes, e.g, catalase, SOD, and the enzymes 
involved with regeneration of GSH.  Unfortunately, the equilibrium between endogenous 
antioxidants and ROS can be disrupted, causing oxidative stress and cell death.  This can 
happen with the introduction of cellular stressors, e.g. hypoxia, ETC inhibitors, hydrogen 
peroxide, and ethanol (Abramov et al., 2007; Dabbeni-Sala et al., 2001; Haorah et al., 
2005; Jayalakshmi et al., 2005; Mitsumoto et al., 2002; Muresan and Eremia, 1997).  
There are two explanations for the accumulation of ROS, which is associated with 
oxidative stress (Figure 5).  First, there can be an upsurge of ROS generation, which is 
generally induced by toxins, including ethanol.  Alternatively, oxidative stress can 
develop from insufficient neutralization of ROS.  A malfunction in the endogenous 
mechanisms that degrade the naturally generated ROS results in an accumulation of ROS.  
Elevated levels of ROS can lead to apoptotic cell death (Lee et al., 2005b). 
 Oxidative stress has been implicated in several disease processes, including 
neurodegenerative diseases, liver diseases, and heart diseases [Reviewed in (Hamilton et 
al., 2004; Sun and Sun, 2001; Sun et al., 2001; Wu and Cederbaum, 2003)].  It also 
appears that at least some of the adverse effects of ethanol on developing brain involve 
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oxidative stress.  Oxidative stress could arise from uncoordinated neutralization of ROS 
(Del Maestro and McDonald, 1987) or from a low level of endogenous antioxidants 
(Mavelli et al., 1982), thus leaving the developing brain vulnerable to oxidative stress.   
A genetic form of the human disease Amyotrophic Lateral Sclerosis (ALS) 
illustrates the latter explanation.  That is, a genetic mutation in the gene encoding Cu/Zn-
SOD, one of the endogenous antioxidant enzymes, appears to be associated with 
oxidative stress and the ALS pathology (Rosen, 1993).  In summary, augmented 
generation and/or inadequate degradation of ROS can lead to accumulation of ROS that 
will ultimately result in oxidative stress.  It is important to recognize that in many 
situations the two scenarios interact.  
There are numerous examples of ethanol-associated ROS in brain cells and of a link 
between the increased ROS and cellular damage and death.  Ethanol can both promote 
the formation of ROS (Li et al., 2001a) and reduce the levels of endogenous antioxidants 
such as GSH (Maffi et al., 2008; Watts et al., 2005).  ROS accumulation/oxidative stress 
can ultimately result in cell death [reviewed in (Ryter et al., 2007)].  In fact, the 
Henderson laboratory demonstrated that production of ROS precedes the ethanol-
mediated induction of apoptosis (Ramachandran et al., 2003).  That is, ethanol treatment 
rapidly increased generation of ROS in cultured cortical neurons and continued to raise 
ROS levels (Ramachandran et al., 2003).  These changes resulted in apoptotic cell death.  
In addition, in vitro treatment of neural crest cells with ethanol increases production of 
several ROS, including superoxide, hydrogen peroxide, and hydroxyl radicals.  The 
increased ROS resulted in loss of cell viability (Chen and Sulik, 1996; Davis et al., 1990). 
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Figure 5.  Redox equilibrium and oxidative stress.  In general, normal cells can 
maintain redox equilibrium by balancing the production of ROS and the expression of 
antioxidant enzymes, AnOx (Top).  However, due to the introduction of a stressor 
such as ethanol, an upsurge of ROS production and accumulation can shift the balance 
resulting in oxidative stress (Middle).  Alternatively, a stressor can cause insufficient 
expression of antioxidant enzyme to shift the balance toward oxidative stress.   
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That ethanol can induce ROS generation in multiple areas of the developing brain, 
including cerebellum (Heaton et al., 2002) and cortex (Haorah et al., 2008; 
Ramachandran et al., 2003), shows that an ethanol-associated increase in ROS adversely 
affects multiple brain areas.   
As evidence of the ethanol-associated ROS, there are increased levels of the lipid 
peroxidation product 4-hydroxynenenal (HNE) in cultured rat (Ramachandran et al., 
2001) and human neurons (Haorah et al., 2008). The association between an ethanol-
mediated increase in cell death and an increase in other lipid peroxidation products has 
been reported (Sun et al., 1997; Uysal et al., 1989).  
The ability of antioxidants to reduce ethanol-mediated toxicity provides indirect 
evidence that oxidative stress plays a role in the adverse effects of ethanol.  For example, 
ascorbic acid treatment inhibited ethanol-induced ROS production and prevented growth 
retardation and microencephaly in ethanol exposed embryos (Peng et al., 2005).  Also, 
the ethanol-associated increase in ROS generation and loss of cell viability were 
prevented by catalase in PC12 cells (Sun et al., 1997).  Furthermore, studies from this 
laboratory demonstrated that ethanol-associated apoptosis of fetal rhombencephalic 
neurons was prevented by co-treatment with several different types of antioxidants 
(Antonio and Druse, 2008). 
Ethanol can particularly intensify the generation of ROS because 1) metabolism 
of ethanol by CYP2E1 produces mitochondria-independent ROS (reviewed later), 2) 
ethanol inhibits the mitochondrial electron transport chain, causing a leak of electrons 
which promotes the formation of ROS (reviewed later), and 3) “1” and “2” further 
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damage mitochondria, which results in more ROS production.   Importantly, Lee et al. 
showed that hydrogen peroxide promoted generation of ROS, decrease in mitochondrial 
integrity, and activation of apoptosis, all of which were potentiated by ethanol (Lee et al., 
2005a).  
 The specific mechanisms by which ethanol can increase oxidative stress are 
discussed in subsequent sections.  
 
Metabolism of Ethanol 
 Hepatic oxidation of ethanol by alcohol dehydrogenase (ADH) is the primary 
pathway by which ethanol is metabolized.  In this pathway, the cytosolic enzyme ADH 
catalyzes the conversion of ethanol to acetaldehyde.  Then aldehyde dehydrogenase 
(ALDH) converts acetaldehyde to acetate (Figure 6).  However, there are additional 
enzymes that metabolize ethanol.  A review of the microsomal ethanol-oxidizing system 
(MEOS) described inducible ethanol metabolism by the microsomal enzyme cytochrome 
P-450 2E1 (CYP2E1) (Lieber, 1999).  
Although the liver is the major site of ethanol metabolism, the brain possesses several 
pathways to metabolize ethanol.  Both ADH (Giri et al., 1989; Kerr et al., 1989; Mandel 
et al., 1980; Martinez et al., 2001), and CYP2E1 are present in brain (Warner et al., 1988; 
Warner and Gustafsson, 1994; Wickramasinghe, 1987). In addition, catalase, a 
peroxisomal enzyme normally involved in conversion of hydrogen peroxide to water, can 
metabolize ethanol in brain (Cohen et al., 1980; Zimatkin and Lindros, 1996).  A 
comparative analysis of the ethanol-metabolizing enzymes ADH, CYP2E1, and catalase 
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revealed that catalase is the primary enzyme involved with ethanol metabolism in rat 
brain (Zimatkin et al., 2006).  That is, when ethanol was perfused into the lateral ventricle 
of living rats, acetaldehyde was formed.  However, brain metabolism of ethanol was 
inhibited by a catalase inhibitor.  In fetal brain, it is possible that additional unidentified 
enzymatic pathways might metabolize ethanol.  This possibility was suggested by studies 
in which there was a rapid accumulation of acetaldehyde even in the absence of co-
factors that are required by ADH, CYP2E1, and catalase (Person et al., 2000).   
All the enzymes mentioned in the previous paragraph catalyze ethanol 
metabolism and generate acetaldehyde (Crabb and Liangpunsakul, 2007), which has been 
proven to be toxic to the nerve cells.  The fetus is exposed to acetaldehyde, because 
maternal acetaldehyde diffuses into the fetus through the placenta (Karl et al., 1988).  
Even preimplantation embryos, i.e., before the formation of a placenta, are vulnerable to 
the toxic effects of acetaldehyde (Checiu et al., 1984).  Acetaldehyde induced cell death 
in cultured neurons from the developing rat midbrain (Lee et al., 2005) and caused 
abnormal embryonic growth and development (Giavini et al., 1992). Most of the 
acetaldehyde-mediated toxicity is derived from the ability of this reactive molecule to 
form adducts with macromolecules, i.e., DNA, protein, and lipids.  Acetaldehyde can 
bind to DNA and cause genotoxicity (Wang et al., 2000).  In fact, both acute and chronic 
ethanol treatment in vivo caused DNA damage in several brain regions, including the 
cerebellum and hippocampus (Guo et al., 2007).  In addition, the acetaldehyde adducts of 
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Figure 6.  Metabolism of ethanol.  Metabolism of ethanol is well characterized in 
liver.  Alcohol dehydrogenase (ADH) converts ethanol into acetaldehdye, which is 
associated with ethanol-mediated toxicity.  Acetaldehyde dehydrogenase (ALDH) 
converts acetaldehyde into acetate.  CYP2E1 is the microsomal ethanol oxidizing 
system (MEOS) associated enzyme that is induced after chronic alcohol consumption.  
Catalase can also oxidize ethanol.  Interestingly, catalase appears to be the main 
enzyme that metabolizes ethanol in brain {{1304 Zimatkin,S.M. 2006; }}.   
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proteins and lipids are toxic to cells (Nakamura et al., 2003; Niemela et al., 1998; 
Niemela et al., 2002).  Taken together, metabolism of ethanol, which occurs in the brain, 
produces acetaldehyde.  Acetaldehyde production, in part, could contribute to ethanol-
mediated cellular toxicity.  
 
Reactive Oxygen Species and Endogenous Antioxidants 
 
Reactive Oxygen Species 
 Reactive oxygen species are oxygen-containing molecules that are highly reactive 
radicals with an unpaired electron on the oxygen molecule or non-radicals with a highly 
reactive state.   Examples of ROS include the superoxide anion, hydroxyl radical, 
hydrogen peroxide, nitric oxide, and peroxynitrite.  Normal cellular respiration generates 
ROS such as the superoxide anion, which is a precursor to generation of additional 
reactive species [reviewed in (Temple et al., 2005)]. In order to combat increases in 
cellular ROS, cells have endogenous detoxification systems in which normally generated 
ROS are converted to a non-reactive end product, i.e., water.  This process involves 
enzymes such as SOD1, SOD2, catalase, and glutathione peroxidase [reviewed in 
(Temple et al., 2005)] (Figure 7). 
 
Superoxide and Superoxide Dismutase.  During mitochondrial ETC-mediated 
energy production in normal physiological conditions, electrons can leak into the matrix 
or out of the mitochondria (Curtin et al., 2002; de la Monte et al., 2001; Fleury et al., 
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2002; Mansouri et al., 2001) (Figure 8).  Leaked electrons can be directly transferred to 
molecular oxygen, generating superoxide anion (O2•-).  Although not the most reactive 
ROS, superoxide has the potential to generate other highly reactive species.  One such 
species is the hydroxyl radical (•OH), which is generally formed from hydrogen peroxide.  
Superoxide is a ROS itself and an important precursor to other reactive species.  SOD is a 
metal-containing enzyme that catalyzes the conversion of two superoxide ions into 
hydrogen peroxide (H2O2).  There are three isoforms of SOD.  The copper/zinc 
containing form of SOD (Cu/Zn-SOD or SOD1) is located in the cytosol, while the 
manganese containing SOD (Mn-SOD or SOD2) form is found in mitochondria.  SOD3, 
another copper/zinc SOD, is located in extracellular space. 
 
Hydroxyl Radical.  As previously mentioned, the hydroxyl radical is an extremely 
powerful oxidant with high oxidizing potential (Temple et al., 2005) that can react 
immediately with nearby molecules.  For example, polyunsaturated fatty acids react with 
the hydroxyl radical to produce the toxic byproduct 4-hydroxynonenal (4-HNE) (Girotti, 
1998).  Other studies suggested that 4-HNE also increased neuronal vulnerability to 
oxidative stress and induced apoptosis in neurons (Keller et al., 1999; Kruman et al., 
1997; Malecki et al., 2000).  
 
Hydrogen Peroxide, Catalase, and Glutathione Peroxidase.  As noted, hydrogen 
peroxide (H2O2) is generated as a consequence of superoxide metabolism by SOD.  SOD 
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(A) 
 
(B) 
Figure 7.  Degradation of ROS by endogenous antioxidant enzymes.  Cells are 
equipped with endogenous antioxidants to prevent accumulation of ROS.  The 
superoxide anion is reduced by superoxide dismutase to hydrogen peroxide.  
Hydrogen peroxide is further reduced by either catalase or glutathione peroxidase, 
producing water as a final product.  Figure 7 (A) shows the overall reactions in a flow 
chart, while Figure 7 (B) shows individual reactions carried out by each enzyme. 
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Figure 8.  Mitochondrial electron transport chain (ETC) related ROS generation 
and neutralization.  Mitochondrial ETC is one of the sites of ROS production, even 
in normal cells.  Electron leakage can occur and superoxide anion (O2._) can be formed 
in the mitochondrial matrix or cytosol.  In general, ETC complexes I and III are 
believed to be the sites of electron leakage.  There are endogenous antioxidant 
enzymes that help degrade toxic ROS from accumulating.  Normally, SOD2 and 
glutathione peroxidase (GPO) are found in the mitochondrial matrix while SOD1 and 
catalase are located in cytosol.   
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catalyzes the formation of hydrogen peroxide from two superoxide radicals.  Due to its 
relative stability (Table 1), hydrogen peroxide has been used as an exogenous agent to 
induce oxidative stress, i.e. accumulation of ROS, (Jakubowski and Bartosz, 2000; 
Oyama et al., 1994).  However, hydrogen peroxide can also be metabolized through the 
Fenton or Haber-Weiss reactions to form the hydroxyl radical (Figure 9) or it can be 
reduced to the non-reactive water molecule by the actions of catalase and/or glutathione 
peroxidase.  Catalase, which is mainly found in peroxisomes, is said to be “one of the 
most active catalysts produced by nature”; it has a high affinity for hydrogen peroxide 
and can rapidly detoxify this molecule (Scandalios, 2005).   
 
Possible sources of reactive oxygen species: control conditions versus ethanol treatment 
As noted, cells normally generate ROS as part of the mitochondrial process of 
energy production [reviewed in (Temple et al., 2005)].  In the following section two 
major sources of superoxide that can trigger the production of additional ROS will be 
discussed.  
 
Mitochondrial electron transport chain (ETC).  In aerobic cells, oxidative 
phosphorylation accounts for 90-95% of energy production; this process involves 
mitochondrial utilization of oxygen.  Located in the inner membrane of the 
mitochondrion, the ETC generates a proton gradient that drives the production of ATP 
(Figure 8).  The ETC is comprised of four oxidoreductase complexes (complex I, II, III, 
IV).  Complex I oxidizes NADH and transfers protons to inner membrane space. This  
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Reactive Oxygen Species  Reduction Potential 
(Eo/mV) Hydroxyl radical  +2310 
Hydrogen peroxide  +320 
Iron complex  +120 
Superoxide  ‐330 
 
Table 1.  Reduction Potential of Major Reactive Oxygen Species.  The 
reduction potential of ROS indicates its ability to oxidize a nearby molecule.  The 
hydroxyl radical is more highly reactive than its precursor hydrogen peroxide.  In 
contrast, superoxide is not as reactive as its byproduct hydrogen peroxide.  
Therefore, superoxide is a substrate, which is a precursor to more highly reactive  
ROS.   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Figure 9.  Production of the hydroxyl radical.  Haber-Weiss and Fenton reactions 
potentiate the generation of the hydroxyl radical from superoxide and hydrogen 
peroxide.   
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ETC process also generates two electrons, which are transferred to coenzyme Q (also 
known as ubiquinone) through a semiquinone free radical intermediate.  Ubiquinone then 
carries the electrons to complex III, where these electrons are transferred to cytochrome 
C.  Cytochrome C carries the electrons to complex IV, which transfers them to molecular 
oxygen, generating water in the matrix.   
It is believed that mitochondria can generate ROS, due to insufficient transfer of 
electrons and electron leakage into the matrix.  Within the matrix the electrons will react 
with oxygen to produce the superoxide anion, which can produce additional ROS (Curtin 
et al., 2002; de la Monte et al., 2001; Fleury et al., 2002; Mansouri et al., 2001).  
Complex I and complex III appear to be the major sites of ROS formation.  As 
mentioned, semiquinone, produced by electron transfer in complex I, is a free radical 
intermediate, and thus has the ability to generate the superoxide anion (Boveris et al., 
1976).  High production of mitochondrial hydrogen peroxide was reported during oxygen 
consumption, and this process was associated with complex I (Liu et al., 2002).  
However, the ROS increase was prevented by pre-treatment with coenzyme Q 
(Somayajulu et al., 2005).   
 A comprehensive review by Cahill et al. discussed the effects of ethanol on 
mitochondria dysfunction (Cahill et al., 2002).  Growing evidence suggests that ethanol 
potentiates mitochondrial ROS generation by negatively affecting the ETC.  Chronic 
ethanol treatment leads to decreased ETC respiratory rates (Novack et al., 1982; Thayer 
and Rubin, 1981).  In fact, ethanol inhibited complex I-, II-, and III-dependent oxidative 
processes.  The latter effects were reversible (Kayser et al., 2003).  Studies that used 
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inhibitors of ETC complexes also demonstrated ethanol-associated ROS production, 
particular involving complexes I and III (Bailey et al., 1999).  Interestingly, ethanol 
further affects the health of mitochondria by damaging mitochondrial DNA, 
mitochondrial ribosomes, and mitochondrial membrane permeability (de la Monte et al., 
2001; Holmuhamedov and Lemasters, 2009; Pastorino et al., 1999; Patel and 
Cunningham, 2002; Yan et al., 2007). 
  
Microsomal CYP2E1.  The normal physiological function and the pathological 
function of CYP2E1 are discussed in depth by Cederbaum (Cederbaum, 2006).  CYP2E1 
appears to be involved with the development of alcoholic liver disease.  As mentioned in 
a previous section (See Ethanol Metabolism), the microsomal ethanol-oxidizing system 
(MEOS) can metabolize ethanol by an enzyme called CYP2E1.  While inhibition of 
CYP2E1 prevented alcoholic liver disease (Sun et al., 2001), overexpression of CYP2E1 
resulted in a significantly increased level of hydrogen peroxide (40%-50% increase) 
(Mari and Cederbaum, 2000).  According to Cederbaum, production of the hydroxyl 
radical occurs in microsomes, and oxidation of ethanol potentiates its production 
(Cederbaum, 2006).  Even though a great deal of research focused on hepatic CYP2E1’s 
contribution to oxidative stress in liver, there is also evidence that CYP2E1 is expressed 
in several brain regions, including the cortex, cerebellum, dentate gyrus, and 
hippocampus (Upadhya et al., 2000).  Importantly, ethanol significantly increased 
CYP2E1 expression in all these brain areas as well as in astrocytes (Montoliu et al., 
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1995).  Therefore, it is likely that CYP2E1 plays a significant role in mediating oxidative 
stress and augmenting cellular toxicity.  
 
Increased ROS Can Potentially Influence Cell Signaling 
Even though most of the toxic effects of ROS have been attributed to oxidative 
stress and cell death, there is evidence that ROS participate in cell signaling (Hancock et 
al., 2001).  ROS-mediated cell signaling resembles that of other second messengers.  
ROS are small molecules.  They are quickly metabolized, and they are mobile within the 
cell.  A comprehensive review discussed multiple sites at which ROS could influence cell 
signaling (Figure 10).  These sites include transcription factors, growth factor signaling, 
receptor mediated phosphorylation, and lipid-mediated signaling [reviewed in (Poli et al., 
2004)].  One of the more interesting effects of ROS is on transcription factors such as 
nuclear factor-κB (NF-κB), activator protein-1 (AP-1), and NF-E2 related factor (NRF-
2), because they have been associated with the transcription of several antioxidant genes 
(Dong et al., 2008; Pinkus et al., 1996; Rojo et al., 2004).  For instance, acute exercise-
associated ROS activated the translocation and binding of NF-κB subunits to DNA (Ji et 
al., 2004).  This resulted in the upregulation of endogenous antioxidants (Hollander et al., 
2001).  Addition of hydrogen peroxide also activated NF-κB through the canonical 
pathway (phosphorylation-mediated degradation of IκB that otherwise sequesters NF-κB) 
(Schreck et al., 1991), and through an IκB-independent mechanism.  The latter 
mechanism involved the modulation of DNA-binding subunits (Poli et al., 2004).  In fact, 
NF-κB activation showed sensitivity to redox changes that did not depend on  
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Figure 10.  ROS activation of transcription factors can lead to gene expression.  
ROS is a small and mobile molecule that has been studied as a possible second 
messenger to activate signaling pathways.  This activation can lead to subsequent 
activation of transcription factors.  Also, some of these transcription factors are likely 
to be sensitive to redox status and can be directly activated by ROS. 
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IκB degradation (Canty et al., 1999; Glineur et al., 2000).  Others also demonstrated that 
ROS could activate additional signaling pathways upstream of NF-κB pathway, including 
those involving mitogen-activated protein kinase (MAPK) (Kanterewicz et al., 1998), c-
Jun NH2-terminal kinase (JNK)(Crossthwaite et al., 2002), and PI-3KpAkt (Butts et al., 
2003).  This topic is relevant to this dissertation, which studied the effects of ethanol and 
ipsapirone on the expression of three NF-κB dependent genes that encode antioxidant 
enzymes.
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CHAPTER 3 
IPSAPIRONE ASSOCIATED REDUCTION OF REACTIVE OXYGEN SPECIES IN 
ETHANOL-EXPOSED FETAL RHOMBENCEPHALIC NEURONS 
 
Abstract 
 Recent studies indicate that apoptosis significantly contributes to ethanol-
associated neuronal cell death in liver, lung, and brain (Brown et al., 2001; Ikegami et al., 
2003; Szuster-Ciesielska et al., 2009).  One factor that triggers apoptosis is the increased 
levels of reactive oxygen species (ROS) that can accompany alcohol exposure and other 
stresses.  Previous findings demonstrated that serotonin-1A (5-HT1A) agonists prevented 
apoptosis in the developing neurons after ethanol exposure (Tajuddin and Druse, 2001).  
One potential mechanism by which a 5-HT1A agonist such as  ipsapirone exerts its 
neuroprotective effects is through an up-regulation of the expression of the NF-κB 
dependent pro-survival genes such as Xiap and Bcl-XL (DRUSE ET AL., 2006).  The present 
study shows that an acute in vitro treatment with ethanol rapidly increased the generation 
of ROS, measured using an intracellular ROS-sensitive fluorescent dye, in fetal 
rhombencephalic neurons.  The acute ethanol-associated increase in ROS was not 
prevented by ipsapirone co-treatment of these neurons.   However, the increased ROS 
was prevented in neurons that were pre-treated for 24 hours with ipsapirone before the
addition of ethanol.  Thus, 5-HT1A agonist-associated pro-survival effects may also 
involve reduction of ethanol-induced ROS and oxidative stress. 
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Introduction 
Even though ethanol-induced apoptotic cell death in the developing central 
nervous system is well documented, the underlying mechanism has not been fully 
elucidated.  Considerable evidence suggests that one possible mechanism of ethanol-
associated apoptotic death of neurons is mediated by oxidative stress (Heaton et al., 
2003c; Perez et al., 2006), 
Ethanol can augment oxidative stress by promoting the formation of ROS (Li et 
al., 2001a) and by reducing the levels of endogenous antioxidants such as GSH (Maffi et 
al., 2008; Watts et al., 2005).  Evidence of ethanol-associated oxidative stress have been 
found in vivo and in vitro, and in tissue from multiple brain areas (Haorah et al., 2008; 
Heaton et al., 2002; Ramachandran et al., 2003).  As shown by the Henderson laboratory, 
an elevation in ROS precedes the ethanol-mediated induction of apoptosis 
(Ramachandran et al., 2003).  Other laboratories also showed that increased ROS resulted 
in a loss of cell viability (Chen and Sulik, 1996; Davis et al., 1990). Additional evidence 
that oxidative stress plays a role in the adverse effects of ethanol comes from studies that 
showed that antioxidants and/or antioxidant enzymes can reduce ethanol-mediated  
toxicity (Antonio and Druse, 2008; Peng et al., 2005; Sun et al., 1997).  Taken together, 
ethanol treatment increases ROS, and this increase can precede ethanol-mediated 
apoptosis in developing neurons.   
Oxidative stress occurs when high levels of ROS that are not sufficiently dealt 
with and thus accumulate.  In general, there are two ways that ROS can accumulate.  
ROS levels can rise if there is decreased detoxification of ROS due to lower levels of 
antioxidant enzymes (Naziroglu et al., 2003).  This possibility will be examined in the 
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next chapter.  Alternatively, ROS generation could be augmented following treatment 
with a stressor such as ethanol (Augustyniak and Skrzydlewska, 2009).  The latter 
possibility is examined in this chapter.  
In both in vivo and in vitro studies this laboratory showed that 5-HT1A agonists 
exert neuroprotection against ethanol-induced loss of neurons (Druse et al., 2005; Druse 
et al., 2004; Druse et al., 2006; Tajuddin and Druse, 1999; Tajuddin and Druse, 2001).  In 
fact, an in vitro study showed that co-treatment of fetal rhombencephalic neurons with 
the 5-HT1A agonist ipsapirone prevented ethanol-induced apoptosis and that a receptor 
antagonist blocked the neuroprotective effects of ipsapirone (Druse et al., 2004).  
Interestingly, a study from another laboratory suggested that one mechanism underlying 
the protective effects of a 5-HT1A agonist involved its ability to attenuate oxidative stress 
that was caused by hydrogen peroxide, a major ROS within a cell (Lee et al., 2005b).  
Because 5-HT1A agonists can prevent apoptosis (Ahlemeyer and Krieglstein, 1997; 
Suchanek et al., 1998), including ethanol-induced apoptosis (Druse et al., 2004), it is 
possible that the anti-apoptotic effects of 5-HT1A agonists might involve reducing the 
ethanol-associated ROS increase. 
The current study measured intracellular levels of ROS in control and ethanol-
treated fetal rhombencephalic neurons.  This study also evaluated the potential of the 5-
HT1A agonist ipsapirone to prevent the ethanol-associated rise in ROS.  In order to 
measure intracellular ROS in the culture system used by this laboratory, a modified 
method was developed that utilized the ROS sensitive fluorescent dye 2’,7’-
dichlorodihydrofluorescein diacetate (H2DCF-DA) (Wang and Joseph, 1999). 
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Materials and Methods 
Fetal Rhombencephalic Neuronal Cultures  
The brain region which contains the developing 5-HT neurons (Konig et al., 
1988), i.e., the fetal rhombencephalon, was removed (Eriksen et al., 2002) from timed-
pregnancy Sprague-Dawley rats (175-185 grams) at gestation day 14 (G14), where G=0 
corresponds to the day of insemination.  Throughout the dissection procedure, tissue 
samples were kept ice-cold in Hank’s balanced buffered solution (HBSS), and sterile 
instruments and techniques were used.  As previously described by this laboratory (Druse 
et al., 2005; Druse et al., 2004; Druse et al., 2006; Druse et al., 2007), rhombencephalic 
tissue was mechanically disaggregated before seeding on the 1st day in vitro (DIV 1).  
Cells were seeded onto either poly-D-lysine coated cover glass (Corning, Corning, New 
York) for confocal microscopy, chambered slides (Nunc, Rochester, NY) for 
immunohistochemistry and fluorescence microscopy, or 96-well plates (Corning, 
Corning, New York) for the fluorescent microplate reader.  The seeding density varied 
based on the size of the culture plate: 8x106 cells/plate (55 cm2), 3x105 cells/chamber 
slide (1.8 cm2), or 4x104 cells/well (0.32 cm2).  Cultures were maintained in a neuron-
specific chemically modified media (CMM) that included Dulbecco’s Minimal Essential 
Media/F12 (DMEM/F12) media (Invitrogen, Carlsbad, CA), hydrocortisone-21 sulfate 
(Sigma, St. Louis, MO), Basal Medium Eagle Vitamin Solution (Sigma, St. Louis, MO), 
antibacterial agent gentamicin sulfate (Honegger and Monnet-Tschudi, 1997), B27 
serum-free medium supplement (Invitrogen, Carlsbad, CA) (Brewer et al., 1993), and 
0.25% fetal bovine serum (FBS) (Druse et al., 2004).  After 24 hours, 0.4 µM cytosine 
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arabinoside (Sigma, St. Louis, MO) was added to arrest gliogenesis.  Cells were grown in 
control media (no ethanol) for 5 days, with media changes made on alternate days.   
 
Immunohistochemistry 
 Fetal rhombencephalic neurons were seeded on DIV 1 as described above.  On 
DIV 5 cultures were washed with warm PBS and fixed with 4% paraformaldehyde.  The 
antibody for the 5-HT1A receptor (ImmuoStar, Hudson, WI) was diluted 1:200 in PBS.  A 
Vectastain secondary antibody kit (Vector Labs, Burlingame, CA) and DAB substrate kit 
(Vector Labs, Burlingame, CA) were used to visualize the immunostained receptors. 
To assess the contribution of astrocytes to the cultures immunohistochemistry was 
performed using an antibody to glial fibrillary acidic protein (GFAP).  This method 
confirmed that astrocytes comprised < 5% of the cells in these neuronally-enriched 
cultures.  All animal care and use procedures were reviewed and approved by the 
Institutional Animal Care and Use Committee at Loyola University Chicago, Stritch 
School of Medicine.   
 
Measurement of Reactive Oxygen Species Generation  
Fluorescent Microplate Reader and Confocal Microscopy.  Fetal 
rhombencephalic neurons were seeded on DIV 1 as described above.  On DIV 5 or DIV 6 
cultures were washed with warm PBS with Ca2+/Mg2+ (Thermo Scientific, Waltham, 
MA), and membrane permeable 50 µM H2DCF-DA (Sigma, St. Louis, MO) was added.  
Cells were placed in an incubator at 37 ˚C for 30 minutes.  During this period H2DCF-
DA becomes hydrolyzed and impermeable.  Cells were washed once or twice with PBS 
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before the addition of the treatments.  Treatments included 0, 10, 25, or 50 mM ethanol, 0 
or 200 µM hydrogen peroxide, or 0 or 100 nM ipsapirone.  As a reference, 50 mM 
ethanol is equivalent to 230 mg/dL, which is a commonly seen blood alcohol level in 
binge drinkers.  For studies using the fluorescent microplate reader (Molecular Devices, 
Suunyvale, CA), readings were taken immediately after the addition of treatment.  For 
confocal imaging, the cover glass was placed on a special chassis that had a solution 
chamber for live cell imaging.  Live cell images were taken using a Zeiss LSM-510 
confocal microscope (Zeiss, Thornwood, NY).   
Fluorescence microscopy was used to determine the effects of a 24-hour pre-
treatment with ipsapirone on ROS levels in cultures subsequently treated with 0 or 50 
mM ethanol for 2 hours.  In these studies, the Pre-Ipsapirone treatment group was treated 
on DIV5 with100 nM ipsapirone for 24 hours.  This concentration of ipsapirone promotes 
the development of 5-HT neurons (Whitaker-Azmitia et al., 1996) and prevents apoptosis 
in fetal rhombencephalic neurons (Druse et al., 2004).  On DIV 6, culture medium was 
removed and replaced with phenol red free DMEM/F12 containing either 0 or 50 mM 
ethanol for 2 hours at 37 ˚C.  During the last 30 minutes of the treatments, H2DCF-DA 
(10 µM) was added.  The cells were washed once with warm HBSS with Ca2+/Mg2+ 
(Invitrogen, Carlsbad, CA) and cells were mounted in HBSS for imaging. Fluorescent 
images were typically taken within 1 minute after mounting using a fluorescent 
microscope (Nikon, Tokyo, Japan). 
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Statistical Analyses 
 Statistical analyses of the control and ethanol data obtained using the microplate 
reader were analyzed using a T-test. A p value < .05 was considered to be significant. 
 
Results 
The fetal rhombencephalic neurons express 5-HT1A receptors 
Because these studies involve the treatment of fetal rhombencephalic neurons 
with the 5-HT1A agonist ipsapirone, it was important to demonstrate that the cultures of 
fetal rhombencephalic neurons contain the 5-HT1A receptors.  Immunohistochemistry was 
used to demonstrate that the 5-HT1A receptor was present both on cell bodies and axons 
(Figure 11).   
 
The fluorescent dye H2DCF-DA is sensitive to changes in intracellular ROS 
 The fluorescent dye H2DCF-DA is an intracellular ROS detector (Figure 12) and 
has been used in various cell types (Post et al., 1998; Xu et al., 2004; Zhang et al., 2001).  
Previously, the use of this dye was not evaluated in live neuronal cultures maintained in 
low serum, such as that used in the present investigation. 
Several experiments were performed to optimize assay conditions and to establish 
that the DCF method could be used to detect changes in intracellular ROS levels in fetal 
rhombencephalic neurons.  In Figure 13, fluorescence intensities of two selected neurons 
were measured over time using a confocal microscope.  As soon as hydrogen peroxide 
was added, fluorescence intensities steadily increased over 100 seconds.  In other 
experiments, a fluorescent microplate reader was used to assess relative levels of ROS 
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over a longer period of time (Figure 14).  Fluorescence microscopy was suitable for a 
rapid qualitative observation, whereas the fluorescent microplate reader allowed 
quantitative data collection over a longer interval.  Both methods confirmed that H2DCF-
DA is sensitive to detect ROS.   
 
Ethanol causes a dose- and time-dependent ROS increase 
 H2DCF-DA was used to measure the effects of ethanol on ROS levels in fetal 
rhombencephalic neurons.  After the addition of ethanol the relative fluorescence 
intensity increases in a dose-dependent manner over an ethanol concentration range of 10 
to 50 mM.  The increase continues for at least 30 minutes (Figure 15).  In comparison to 
control conditions, all three concentrations of ethanol (10, 25, 50 mM) increased 
intracellular ROS.  Values from ethanol treated cultures were significantly elevated at p < 
.05 or p < .01.  In addition, the ROS levels increased significantly (p < .05) between 10 
minutes and 30 minutes after the addition of 50 mM.  Subsequent studies used the 50 mM 
ethanol dose because it caused an increase of ~50% at 30 minutes, and it is the 
concentration used in previous studies from this laboratory.  Due to procedural 
difficulties in live-cell assays, the changes in intracellular ROS could not be measured 
beyond 2 hours even with microplate reader.  Limited numbers of cells with normal 
neuronal morphology were identified after 2 hours of assay.  Additionally, volatility of 
ethanol posed further limits.  
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Co-treatment with ipsapirone does not attenuate the acute ethanol-associated rise in ROS 
When ipsapirone and ethanol were added simultaneously, ROS levels increased 
significantly in both groups and there was no significant difference in ROS levels in the 
groups treated with ethanol and those co-treated of ipsapirone and ethanol (Figure 16)  
 
Pre-treatment with ipsapirone prevented the ethanol-induced ROS increase 
  In order to determine whether a longer ipsapirone treatment might help combat 
the effects of ethanol, cultures of fetal rhombencephalic neurons were pre-treated with 
ipsapirone for 24 hours before the addition of ethanol.  Relative ROS levels were then 
assessed for 2 hours.  A qualitative comparison of relative ROS levels indicated that the 
24-hour pre-treatment with ipsapirone prevented an increase in ROS that would 
otherwise have occurred following a 2-hour ethanol exposure (Figure 17).  Unpublished 
findings from Roberta Gillespie in this laboratory also showed that a 24-hour pre-
treatment with ipsapirone significantly prevented the ethanol-induced ROS increase 
(Figure 18).  
 
Discussion 
H2DCF-DA is sensitive to ROS changes 
 H2DCF-DA is one of the most widely used fluorescent dyes to measure changes 
in intracellular ROS.  That it can be applied to both live cells and fixed cells makes 
H2DCF-DA very versatile.  Detectable changes in relative fluorescence were detected 
after treatment with hydrogen peroxide, which is both a ROS generator and a major ROS.  
These changes indicated that H2DCF-DA can be used to study the acute effects ethanol 
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on intracellular ROS in primary cultures of fetal rhombencephalic neurons (Figures 13 
and 14).  It should be mentioned that the decreasing slope of the curve in hydrogen 
peroxide treatment in Figure 14 might indicate that rapid death of neurons slowed the 
production of ROS.   
A slow increase in ROS over time was observed in cultures of control neurons (no 
ethanol/no hydrogen peroxide) even though the relative levels of ROS were significantly 
lower (p > .05) than those in cultures of peroxide- or ethanol-treated neurons (Figure 14).  
This increase can be explained in two ways. 1) In order to use H2DCF-DA to measure 
ROS changes, it was necessary to maintain neurons in a media that lacked phenol red and 
supplements, which would have interfered with the detection of fluorescence in the 
cultures.  Thus, they were maintained in a stressful environment, i.e., one that contained 
PBS, HBSS, or DMEM/F12 without phenol red and supplements as control media.  2) 
Cultured primary neurons produce measurable ROS over time as part of normal 
respiration.  
 
Ethanol treatment caused a progressive accumulation of ROS 
Evidence from these and additional studies from this and other laboratories show 
that the effects of ethanol on developing CNS may be caused by oxidative stress 
(Augustyniak and Skrzydlewska, 2009; Heaton et al., 2003c; Perez et al., 2006).  
Oxidative stress occurs when the tightly balanced cellular redox status of cells shifts such 
that ROS levels increase.  This can happen when cellular conditions lead to an upsurge of 
ROS (Augustyniak and Skrzydlewska, 2009) and/or a reduction in endogenous 
antioxidants (Naziroglu et al., 2003).  In the acute ethanol treatment model, it is likely 
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that oxidative stress results from a rapid increase of ROS within the cell.  As previously 
discussed in Chapter 2, a quick ROS increase after ethanol exposure can be caused by 
mitochondrial dysfunction via inhibition of electron transport (Bailey et al., 1999; Kayser 
et al., 2003). 
Consistent with findings from the present study, which demonstrated that acute 
ethanol exposure quickly increased the generation of ROS in cultures of fetal 
rhombencephalic neurons, another laboratory showed that in vitro acute ethanol treatment 
resulted in high levels of ROS within 30 minutes in the developing cortical neurons 
(Ramachandran et al., 2003).  In the present study, 50 mM ethanol caused a progressive 
elevation of ROS over time.  The difference between the relative fluorescence in cultures 
of 50 mM ethanol-treated neurons at 10 and 30 minutes was significant (Figure 15).  This 
is indicative of continuous generation of ROS resulting in ROS accumulation.  Without 
adequate detoxification, this accumulation will lead to significant oxidative neuronal 
damage.   
 
Effects of ipsapirone on the ethanol-induced increase in ROS  
Previous work from other laboratories showed that treatment with one of several 
classical antioxidants can reduce the ethanol-associated oxidative stress (Guo et al., 2007; 
Pirlich et al., 2002) and provide neuroprotection (Heaton et al., 2000; Herrera et al., 
2003).  Most of the classical antioxidants are characterized by their ability to rapidly 
scavenge free radicals or other ROS.  Thus, a reduction of ROS after ethanol exposure 
should accompany an acute co-treatment with any drugs that have the ROS scavenging 
ability.  In fact, previous studies (unpublished) from this laboratory showed rapid free-
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radical scavenging effects by the antioxidant α-lipoic acid after ethanol was added to a 
culture of fetal rhombencephalic neurons.    
The observation from this study that ipsapirone co-treatment did not prevent the 
ethanol-associated ROS increase (Figure 16) indicates that ipsapirone does not possess 
the characteristics of a classical free radical scavenging antioxidant.  However, a 24-hour 
ipsapirone pre-treatment attenuated the ethanol-associated increase in ROS (Figure 17 
and 18), suggesting that ipsapirone exerts indirect antioxidant properties.  Ipsapirone 
might activate downstream regulators of the levels or activity of endogenous antioxidant 
enzymes such as SOD1, SOD2, and catalase.  For example, ipsapirone might alter the 
expression of the gene encoding an antioxidant enzyme, the translation of the message 
into protein, or the stability/turnover of the protein product.  The next chapter describes 
the effects of ipsapirone on the expression and activities of the three noted antioxidant 
enzymes. 
Even though the mechanism is unclear, non-scavenging agents have been 
identified that reduce oxidative stress by regulating the expression of endogenous 
antioxidant enzymes.  In fact, there are number of drugs shown to help reduce oxidative 
stress, although the drugs themselves are not direct scavengers of ROS.  Instead, they 
help facilitate the cellular environments where redox balance is well maintained (Dong et 
al., 2008; Ognjanovic et al., 1995; Warner et al., 1991).  Interestingly, the study has 
demonstrated that the protective mechanism associated with 5-HT1A receptor in part 
included attenuation of oxidative stress caused by hydrogen peroxide (Lee et al., 2005b). 
Transcription factors like NF-κB, AP-1, and Nrf-2 are likely to regulate the 
expression of the genes that encode endogenous antioxidant enzymes (Dong et al., 2008; 
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Pinkus et al., 1996; Rojo et al., 2004).  That ipsapirone’s ability to block an ethanol-
associated increase in ROS required a 24-hour pre-treatment (Figure 17 and 18) is 
consistent with the possibility that its effects were exerted by regulation of gene 
transcription, because both transcriptional changes and subsequent translation require 
time.  In the studies described in subsequent chapter, the effects of ipsapirone on the 
expression of endogenous antioxidant enzymes were examined. 
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Figure 11.  Serotonin-1A receptors are expressed on cell bodies and axons of the 
fetal rhombencephalic neurons.  Primary neuronal culture of G14 fetal 
rhombencephalon on DIV5 (A and B) were fixed in 4% paraformaldehyde followed 
by immunostaining with 5-HT1A primary antibody (B) or without (A).  DAB staining 
was used to visualize 5-HT1A receptors found on cell bodies (arrow heads) and axons 
(arrows) of the neurons. 
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Figure 12.  Schematic illustration of the intracellular ROS detection fluorescent 
dye 2’,7’-dichlorodihydrofluorescein diacetate (H2DCF-DA).  The H2DCF-DA 
molecule is a membrane permeable fluorescent dye.  The diacetate moiety on the 
molecule allows H2DCF-DA to permeate the cell membrane.  Once it enters the 
intracellular space, cellular esterase hydrolyzes the acetate moiety making the 
molecule lipophobic HDCF.  In the presence of ROS, HDCF get oxidized and 
becomes fluorescent DCF.  Fluorescence intensity is correlated with the amount of 
intracellular ROS, e.g. superoxide, hydrogen peroxide, and hydroxyl radicals. 
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Figure 13.  H2DCF-DA detects ROS in primary cultures of fetal rhombencephalic 
neurons using confocal imaging.  The relative levels of reactive oxygen species (ROS) 
were determined using 50 µM 2’,7’-dichlorodihydrofluorescein diacetate (H2DCF-DA).  
Using confocal microscopy, the fluorescence intensity of two marked neurons was 
recorded over time.  (A) Still shots of fetal rhombencephalic neurons exposed to 50 µM of 
H2O2 over a 30 second interval.  (B) A graph depicting fluorescence intensity of the two 
neurons measured over time. 
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Figure 14.  The H2DCF-DA is useful to detect relative ROS levels in primary culture 
of fetal rhombencephalic neurons using a fluorescence microplate reader.  The 
relative levels of reactive oxygen species (ROS) were determined using 2’,7’-
dichlorodihydrofluorescein diacetate (H2DCF-DA) dye.  A fluorescence microplate reader 
was used to detect the fluorescence intensity of the neurons after the addition of PBS 
(Control) or hydrogen peroxide (H2O2 200 µM) over a 60 minute interval.  Values that are 
significantly different from the time-matched control value at p < .01 are represented by 
the **. 
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Figure 15.  Ethanol induces a dose-dependent and time-dependent increase in 
reactive oxygen species in fetal rhombencephalic neurons.  The relative levels of 
reactive oxygen species (ROS) was determined using 2’,7’-dichlorodihydrofluorescein 
diacetate (H2DCF-DA) dye.  Fluorescence intensity was measured after the addition of 
ethanol (10, 25, 50 mM) over a 30-minute interval.  (A) A scatter plot with 
measurements at 5-minute intervals over a period of 30 minutes.  (B) A bar graphic 
representation of relative fluorescence at 10, 20, and 30-minutes.  Values that are 
significantly different from the time-matched control value at p < .05 and p < .01 are 
represented by the * and **, respectively.  
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Figure 16.  Co-treatment with ipsapirone did not reduce the ethanol-induced 
ROS increase in fetal rhombencephalic neurons.  The generation of reactive 
oxygen species (ROS) was determined using 50 µM 2’,7’-dichlorodihydrofluorescein 
diacetate (H2DCF-DA) dye.  Fluorescence intensity was measured after the addition of 
PBS (Control), 50 mM ethanol (Ethanol), 100 nM ipsapirone (Ipsapirone), and ethanol 
and ipsapirone (Ipsapirone + Ethanol) at the same time and over a 30-minute interval.  
The results show that co-treatment with ipsapirone did not prevent ethanol-induced 
ROS. ncrease. 
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Figure 17.  A 24-hour pre-treatment with ipsapirone prevents the ethanol-
associated increase in ROS.  The generation of reactive oxygen species (ROS) was 
determined using 2’,7’-dichlorodihydrofluorescein diacetate (H2DCF-DA) dye.  
Ipsapirone treatment was initiated 24 hours prior to the addition of ethanol.  The 
fluorescent images were captured from cultures that were maintained in HBSS for 2 
hours (Control 2-Hour) or in cultures that were treated with 50 mM ethanol for 2 
hours (Ethanol 2-Hour) or pre-treated with ipsapirone for 24 hours before the addition 
of ethanol (Pre-Ipsapirone 24-Hour + Ethanol 2-Hour).  Pre-treatment with ipsapirone 
prevented ethanol-induced ROS increase. 
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Figure 18.  A 24-hour pre-treatment with ipsapirone prevents the ethanol-
associated increase in ROS in fetal rhombencephalic neurons.  The generation of 
reactive oxygen species (ROS) was determined using 2’,7’-dichlorodihydrofluorescein 
diacetate (H2DCF-DA) dye.  Ipsapirone treatment was initiated 24 hours prior to the 
addition of ethanol.  The relative fluorescence was measured using a fluorescence 
plate reader after cultures were maintained for 30 minutes in PBS (Control) or 50 mM 
ethanol (Ethanol and Pre-Ipsapirone + Ethanol).  Values that are significantly different 
from control and ethanol value at p <.05 are represented by the * and #, respectively.  
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CHAPTER 4 
EFFECTS OF ETHANOL AND IPSAPIRONE ON THE EXPRESSION OF GENES 
ENCODING ANTIOXIDANT ENZYMES IN ETHANOL-TREATED NEURONS 
 
Abstract 
The preceding chapter showed that ethanol increased ROS, while simultaneous 
treatment with ipsapirone did not prevent the increase in fetal rhombencephalic neurons.  
However, 24-hour pre-treatment with ipsapirone prevented the ethanol-associated 
increase in ROS.  The findings suggest ipsapirone-associated ROS reduction might 
involve transcriptional activation of endogenous antioxidants.  Previous findings from 
this laboratory demonstrated that a 24-hour co-treatment with the serotonin-1A agonist 
ipsapirone prevented ethanol-associated apoptosis and activated the expression of 
specific NF-κB dependent anti-apoptotic genes, Xiap and Bcl-XL, in ethanol-treated fetal 
rhombencephalic neurons (Druse et al., 2004; Druse et al., 2006).  The present study 
investigated: 1) the temporal effects of both ethanol and ipsapirone on the expression of 
Sod1, Sod2, and catalase, which encode for endogenous antioxidants enzymes and 2) the 
effects of the SOD/catalase mimetic EUK-134 on the prevention of ethanol-induced 
apoptosis.  Enzyme activities of superoxide dismutase and catalase were also measured.  
Expression of Sod2 and catalase demonstrated an early activation by ethanol.  After a 
brief treatment with 50 mM ethanol, i.e., 2-hour and 8-hour, Sod2 and catalase were 
90 
 
significantly increased, respectively, possibly as an initial attempt to survive.  An 
ethanol-associated increase in catalase was followed by a rise in catalase activity.  Both 
catalase expression and activity returned to levels found in unstressed controls.  A late 
activation, i.e. 24-hour, of Sod1 and Sod2 by ethanol was detected.  Total SOD enzyme 
activity resembled the changes seen in Sod1 gene expression.  Importantly, treatment 
with ipsapirone augmented the activity of catalase and the expression of catalase in 
ethanol-treated neurons at later time points.  The latter effects are likely to contribute to 
the pro-survival effects of ipsapirone.  EUK-134 prevented ethanol-induced apoptosis in 
a dose-dependent manner, suggesting the importance of the endogenous antioxidants in 
the prevention of ethanol toxicity in developing neurons.  
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INTRODUCTION 
In utero ethanol exposure can cause serious functional and structural 
abnormalities in the brain of the developing fetuses.  Included among the CNS disorders 
associated with Fetal Alcohol Syndrome (FAS) and/or Fetal Alcohol Spectrum Disorder 
(FASD) are problems with attention, behavior, cognition, memory, and executive 
function (Mattson et al., 1996; Riley et al., 2003; Wattendorf and Muenke, 2005).  In 
addition, morphological abnormalities are found in several brain regions, including the 
corpus callosum, cerebellum, and basal ganglia (Riley et al., 2004; Roebuck et al., 1998).  
Although the mechanism(s) by which alcohol exposure effects the deleterious changes in 
the developing brain have not been fully elucidated, both in vivo and in vitro animal 
studies suggest that apoptosis is likely to be involved (Castoldi et al., 1998; Cheema et 
al., 2000; Ikonomidou et al., 2000; Ramachandran et al., 2001). 
Earlier studies from this (Druse et al., 1999; Tajuddin and Druse, 2001) and 
another laboratory (Sari and Zhou, 2004) showed that in utero ethanol exposure caused a 
significant reduction in serotonin (5-HT) neurons.  Using a 24 hour treatment of fetal 
rhombencephalic neurons with 50 mM ethanol, in vitro studies established that this 
reduction was probably caused by ethanol-associated apoptosis (Druse et al., 2005; Druse 
et al., 2004; Druse et al., 2007), a decreased activity of the phosphatidylinositol 3-kinase 
(PI3K)  pAkt pro-survival pathway (Druse et al., 2005) and reduced downstream 
expression of several NF- κB dependent anti-apoptotic genes: Xiap, Ciap1, Ciap2, Bcl-2 
and Bcl-XL (Druse et al., 2006; Druse et al., 2007).  Importantly, in vivo and in vitro 
treatment with the 5-HT1A agonist ipsapirone prevented the ethanol-associated reduction 
of 5-HT and other fetal rhombencephalic neurons and the ethanol-associated decrease of 
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pAkt (Druse et al., 2005; Druse et al., 2004; Tajuddin and Druse, 1999; Tajuddin and 
Druse, 2001).  Ipsapirone was able to increase expression of NF-κB dependent genes that 
encode XIAP and Bcl-XL in fetal rhombencephalic neurons treated with ethanol for 24 
hours prior to the addition of ipsapirone (Druse et al., 2006). 
One way by which ethanol augments apoptosis is by increasing oxidative stress.  
In fact, several laboratories, including this one, have shown that ethanol increases 
reactive oxygen species (ROS) in developing neural tissue (Heaton et al., 2002; 
Ramachandran et al., 2003; Watts et al., 2005).  The increased oxidative stress is 
associated with augmented apoptosis (Ramachandran et al., 2003), and co-treatment of 
fetal rhombencephalic neurons with specific antioxidants prevents ethanol-associated 
apoptosis (Antonio and Druse, 2008).  Antioxidant treatment also prevents damage to 
ethanol-exposed cerebellar granule cells (Heaton et al., 2004b; Siler-Marsiglio et al., 
2004) and hippocampal neurons (Marino et al., 2004), although it has not proved 
neuroprotective in all studies (Grisel and Chen, 2005; Tran et al., 2005). 
Of particular interest to the current study are the antioxidant enzymes SOD1, 
SOD2, and catalase; these are endogenous antioxidants that participates in reactions that 
detoxify ROS.  These enzymes are of interest both because of their roles as antioxidant 
enzymes and because there is evidence that Sod1, Sod2, and catalase are expressed in a 
NF-κB dependent manner (Furukawa et al., 1997; Rojo et al., 2004; Zhou et al., 2001a).  
Interestingly, catalase is also reportedly the key enzyme involved in ethanol metabolism 
in the brain of rodents (Zimatkin et al., 2006).  Considering that the 5-HT1A agonist 
ipsapirone upregulates the NF-κB genes encoding the anti-apoptotic proteins Bcl-XL and 
XIAP (Kucharczak et al., 2003), this drug might also augment the expression of the three 
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endogenous antioxidants; such an effect could be essential to reducing the ROS-mediated 
apoptosis caused by ethanol.   
In order to better understand the contribution of potential neuroprotective effects 
of ipsapirone, this study evaluated the time course associated with the effects of 
ipsapirone and ethanol the genes that encode the antioxidant enzymes SOD1, SOD2, and 
catalase.  This study also examined the effects of ethanol and ipsapirone on total SOD 
and catalase activity.   
 
MATERIALS AND METHODS 
In vitro fetal rhombencephalic neuronal cultures  
The methods used in this study have been described previously in several earlier 
publications from this laboratory (Druse et al., 2005; Druse et al., 2004; Druse et al., 
2006; Druse et al., 2007).  All animal care and use procedures were reviewed and 
approved by the Institutional Animal Care and Use Committee at Loyola University 
Chicago, Stritch School of Medicine.  The brain region that contains the developing 5-HT 
neurons (Konig et al., 1988), i.e., the fetal rhombencephalon, was removed  (Eriksen et 
al., 2002) from timed-pregnancy Sprague-Dawley rats (175-185 grams) at gestation day 
14 (G14), where G=0 corresponds to the day of insemination.  Throughout the dissection 
procedure, tissue samples were kept ice-cold in Hank’s balanced buffered solution 
(HBSS), and sterile instruments and techniques were used.  Rhombencephalic tissue was 
mechanically disaggregated before seeding onto poly-D-lysine coated plates (Corning, 
Corning, New York) at a density of 8x106 cells/plate (55 cm2).  Cultures were maintained 
in a neuron-specific chemically modified media (CMM) that included Dulbecco’s 
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Minimal Essential Media/F12 (DMEM/F12) media (Invitrogen, Carlsbad, CA), 
hydrocortisone-21 sulfate (Sigma, St. Louis, MO), Basal Medium Eagle Vitamin Solution 
(Sigma, St. Louis, MO), antibacterial agent gentamicin sulfate (Honegger and Monnet-
Tschudi, 1997), B27 serum-free medium supplement (Invitrogen, Carlsbad, CA) (Brewer 
et al., 1993), and 0.25% fetal bovine serum (FBS) (Druse et al., 2004).  After 24 hours, 
0.4 µM cytosine arabinoside (Sigma, St. Louis, MO) was added to arrest gliogenesis.  
Immunohistochemistry was performed using an antibody to glial fibrillary acidic protein 
(GFAP) to assess the contribution of astrocytes to the cultures; this method confirmed 
that astrocytes comprised < 5% of the cells in these neuronally-enriched cultures.  Cells 
were grown in control media (no ethanol) for 5 days, with media changes made on 
alternate days.  
 
Treatments 
The fetal rhombencephalic neurons were cultured until DIV 5 according to the 
method described previously.  Using an ethanol chamber system described by this 
laboratory (Druse et al., 2004), cultures were divided into four groups for RNA isolation 
and enzyme activity assays: Control (no ipsapirone/ no ethanol), Ipsapirone (100 nM 
ipsapirone), Ethanol (50 mM ethanol), and Ethanol + Ipsapirone (50 mM ethanol + 100 
nM ipsapirone).  For the Ethanol + Ipsapirone group, treatment was employed at the same 
time (co-treatment).  The concentration of ipsapirone used in this project was found to 
promote the development of 5-HT neurons (Whitaker-Azmitia et al., 1990) and prevent 
apoptosis in fetal rhombencephalic neurons (Druse et al., 2004).    
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RNA Isolation and cDNA Synthesis 
 Neurons were treated for different periods, ranging from 2 hours to 48 hours.  
Trizol reagent (Life Technology, Gaithersburg, MD) (Druse et al., 2006; Druse et al., 
2007; Lee et al., 2009) was used to extract total RNA from cultured fetal 
rhombencephalic neurons.  Glycogen (20 mg/ml) (Ambion, Austin, TX) was included to 
facilitate the precipitation of RNA and to maximize the yield of RNA.  RNA was 
dissolved in 25 µl DEPC-treated H2O, which was treated with DNA-free (Ambion, 
Austin, TX) to remove contaminating genomic DNA.  RNA was stored at –80o until use.  
Single strand cDNA was synthesized from 1 to 2 µg of total RNA (DNA-free) using the 
First Strand cDNA synthesis kit (Fermantas, Hanover, MD). 
 
Quantitative real-time RT-PCR 
 cDNA (DNA equivalent of 20 ng to 40 ng of total RNA) was diluted with 
Platinum Quantitative PCR Super Mix-UDG [1.5 U Platinum Taq DNA polymerase, 20 
mM Tris-HCl (pH 8.4), 50 mM KCl, 3 mM MgCl2, 200 mM dGTP, 200 mM dATP, 200 
mM dCTP, 400 mM dUTP, 1 U UDG (Life Technology)], 0.25 mM Rox  (Life 
Technology), 1/40,000 SYBR Green (Molecular Probes, Eugene, Oregon), and primers 
(Druse et al., 2006; Lee et al., 2009).  A Perkin-Elmer Gene Amp 7300 Sequence 
Detector thermal cycler (Applied Biosystems, Foster City, CA) was used for PCR 
amplifications.  RT-PCR data was analyzed using SDS software (Applied Biosystems).  
Sample inputs were normalized using expression of GAPDH.   
 Plasmid containing target genes were used to generate standard curves for real-
time quantitative RT-PCR assays (Druse et al., 2006), and a standard curve was generated 
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from serial dilutions of known amounts of the input copy number of target genes.  
Standard curves for GAPDH and genes of interest (10-100,000 copies/µl) were 
performed in each experiment.  Routinely we included a triplicate RT-PCR reaction 
lacking cDNA or known DNA template for each set of primers.  Specific primary 
sequences for Sod1, Sod2, catalase and GAPDH were selected using the Primer Express 
program (Applied Biosystems, Foster City, CA) and sequences available from the NCBI 
database.  Primers were synthesized by Invitrogen (Carlsbad, CA).  The forward (F) and 
reverse (R) primer sequences for rat genes are included in Table 2.  Typically, GAPDH 
and the three target genes were first detected at 22 or 28 cycles, respectively.  As 
previously described (Druse et al., 2006; Druse et al., 2007) data was analyzed using the 
2-∆∆CT method (Livak and Schmittgen, 2001). 
 
Superoxide dismutase activity assay 
 Neurons were treated for different periods, ranging from 2 hours to 48 hours.  All 
the treatment groups were harvested according to the manufacturer’s protocol provided in 
the assay kit (Cayman Chemical, Ann Arbor, MI).  Treated cells were first washed twice 
with ice cold 1X PBS (pH 7.4) and collected in 300 uL of ice cold lysis buffer [20 mM 
HEPES buffer (pH 7.2) containing 1 mM EGTA, 210 mM mannitol, and 70 mM sucrose] 
using a rubber policeman.  Harvested cells were sonicated followed by centrifugation at 
1,500 x g for 5 minutes at 4°C.  The supernatant was removed and stored at -80°C until 
the day of the assay. 
 On the day of the assay, all the reagents provided in the assay kit were prepared 
according to the manufacturer’s protocol.  The frozen samples were thawed in ice and 
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processed quickly on ice.  Once all the samples and reagents were prepared in the 96-well 
plate, the absorbance was read at 460 nm using a plate reader (Molecular Devices, 
Sunnyvale, CA).  Subsequently, total protein concentration for each sample was 
determined using Lowry’s protein assay (Lowry et al., 1951).  Using the calculation 
formula provided by the manufacturer’s protocol, the superoxide dismutase enzymatic 
activity was determined based on the total amount of the protein in each sample.   
 
Catalase activity assay 
 Neurons were treated for different periods, i.e., 18, 24, or 48 hours.  The activity 
of catalase was determined using an enzymatic kit (Cayman, Ann Arbor, MI).  After 
treatment, the treatment groups were harvested according to the manufacturer’s protocol 
provided in the assay kit (Cayman Chemical, Ann Arbor, MI).  Treated cells were first 
washed twice with ice cold 1X PBS (pH 7.4) and collected in 300 uL of ice cold lysis 
buffer (50 mM potassium phosphate, pH 7.0, containing 1 mM EDTA) using a rubber 
policeman.  Harvested cells were sonicated followed by centrifugation at 10,000 x g for 
15 minutes at 4°C.  The supernatant was removed and stored at -80°C until the day of the 
assay. 
 On the day of the assay, all the reagents provided in the assay kit were prepared 
according to the manufacturer’s protocol.  The frozen samples were thawed in ice and 
processed quickly on ice.  Once all the samples and reagents were prepared in a 96-well 
plate, the absorbance was read at 540 nm using a plate reader (Molecular Devices, 
Sunnyvale, CA).  Subsequently, total protein concentration for each sample was 
determined using Lowry’s protein assay (Lowry et al., 1951).  Using the calculation 
98 
 
formula provided by the manufacturer’s protocol, the catalase enzymatic activity was 
determined based on the total amount of the protein in each sample.   
 
Lowry’s protein assay 
To determine the total protein concentration Lowry’s protein assay was used 
(Lowry et al., 1951).  First, 10 µL of a sample was transferred to a glass test tube.  Also, 
standard protein concentrations were prepared with 5, 10, 20, 30, 40 µL of bovine serum 
albumin (1 mg/mL).  To each tube, 100 µL of 1N NaOH was added and mixed followed 
by 30 minutes incubation at 25°C.  Then, 1 mL of phenol was added to each tube and 
incubated for 30 minutes at 25°C.  Finally, 100 µL of phenol reagent was added to each 
tube for 30 minutes at 25°C followed by absorbance reading at 595 nm. 
 
EUK-134 treatment and Hoechst 33342 staining 
Primary neuronal cultures of fetal rhombencephalon were treated with 0 or 50 
mM ethanol and EUK-134 (0, 0.5 µM or 5 µM) for 24 hours.  Treated cells were then 
stained with Hoechst 33342 as previously described (Antonio and Druse, 2008; Druse et 
al., 2005). 
   
Statistical analyses 
 Data was analyzed using two-way ANOVA and a post-hoc Newman-Keuls or 
Dunnet’s procedure to test our hypotheses that ethanol treatment alters the expression of 
some NF-κB dependent genes that encode antioxidant enzymes and that ipsapirone 
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restores expression in ethanol-treated neurons to levels found in untreated (control) 
cultures. A p value < .05 was considered to be significant. 
 
RESULTS 
Effects of ethanol and ipsapirone on Sod1 
At 2 hours of treatment, ipsapirone significantly increases Sod1 in control (no 
ethanol) neurons and reduces it in ethanol-treated neurons (p<.05) (Figure 19).   In 
addition, ethanol significantly elevated Sod1 in neurons that were maintained under 
control conditions or co-treated with ipsapirone for 24 hours (p < .01) (Figure 20).  
However, by 48 hours there was no longer an ethanol-associated increase in Sod1 (Figure 
21).  Values in the ethanol group returned to control levels by this time, and those in the 
ethanol plus ipsapirone group were lower than those in control (no ethanol neurons) (p < 
.05). 
 
Effects of ethanol and ipsapirone on Sod2  
At the 2-hour time point, ipsapirone augmented expression of Sod2 in both 
control and ethanol-treated neurons (Figure 24).  Ethanol treatment also increased Sod2 at 
this early time.  At 24 hours, ethanol augmented Sod2 in cultures maintained in the 
presence and absence of ipsapirone (p < .05) (Figure 25).  This increase was maintained 
until 48 hours in the Ethanol plus Ipsapirone group (Figure 26), but Sod2 returned to 
control levels in neurons treated only with ethanol.  Although it appears that Sod2 was 
elevated in control cultures at 48 hours (Figures 27 & 28), the difference was not 
significant (p > .05).  
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Effects of ethanol and ipsapirone on SOD activity 
There were only two times when the activity of total SOD activity was affected by 
either ethanol or ipsapirone (Figure 31).  At 2 hours (Figure 29) there was an ipsapirone-
mediated increase in SOD activity (p < .05), and there was a significant decrease at 48 
hours (Figure 30) in the ethanol plus ipsapirone treatment group (p < .05).  At the other 
times examined, the enzyme activities in the treatment groups were comparable to those 
in control neurons.  Because of the low level of activity of the separate enzymes, total 
SOD activity was determined. 
 
Expression and activity changes in catalase  
Treatment of fetal rhombencephalic neurons with 50 mM ethanol caused a modest 
yet significant increase (p < .05) in catalase at 8 hours (Figure 32).  This early elevation 
was brief and transient.  This increase in gene expression was followed by an elevation of 
catalase activity at 18 hours (p < .05) (Figure 36).  A prolonged (24 hour) exposure to 
ethanol brought catalase levels down to those in unstressed controls.  Importantly, 
catalase was significantly elevated in Ethanol plus Ipsapirone-treated cultures (Ethanol + 
Ipsapirone group versus Ethanol group) at 24 hours (p < .05) (Figure 33).  Even when 
compared to control neurons, ipsapirone treatment caused a significant increase in 
catalase at 24 hours.  It should be noted that addition of 100 nM ipsapirone to control 
neurons (Ipsapirone group) significantly augmented the expression of catalase (Figure 
33) at 24 hours (p < .01) when compared to control neurons.  Catalase enzyme activity 
was increased only in the co-treatment group at 48 hours (Figure 37). 
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EUK-134 protects against ethanol-mediated apoptosis 
 When fetal rhombencephalic neurons were treated with ethanol for 24 hours, 
~25%-30% underwent apoptosis.  However, co-treatment with EUK-134, a SOD/catalase 
mimetic, significantly reduced ethanol-associated apoptosis.  This was found when 
neurons were co-treated with either 0.5 µM (p < .05) or 5 µM (p < .01) of EUK-134.  
However, only the higher dose of EUK-134 fully blocked ethanol-associated apoptosis.  
 
DISCUSSION 
Early and transient response to ethanol 
Ethanol treatment caused an early and significant increase in the expression and 
activities of SOD (Figure 22, 23, 27, 28, and 31) and catalase (Figure 34, 35, and 38).  
The present study found an ethanol-associated increase in the expression of the gene 
encoding the antioxidant enzymes SOD2 (2 hours) and catalase (8 hours).  Although the 
ethanol-associated change in Sod2 was not paralleled by a similar change in enzyme 
activity, the significant increase in catalase was followed by a corresponding elevation in 
catalase activity.  Thus, it appears that ethanol causes an early activation of two genes 
that encode antioxidant enzymes and that one of these changes resulted in a change in 
enzyme activity.   
Other investigators report that ethanol augmented the activity and/or expression of 
these antioxidant enzymes.  For example, ethanol treatment elevated SOD activity in the 
developing striatum, hippocampus, and cortex (Enache et al., 2008; Heaton et al., 2003b; 
Heaton et al., 2003c).  In addition, an acute in vivo ethanol exposure resulted in an early 
increase in catalase (Heaton et al., 2003a; Reddy et al., 1999).  Ethanol-associated up-
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regulation of catalase and Sod2 was also detected in hepatic cells (Bardag-Gorce et al., 
2006; Heaton et al., 2003c).  Moreover, additional studies from this laboratory showed 
that the early (2 to 8 hour) response of fetal rhombencephalic neurons to 50 mM ethanol 
correlates with augmented expression of two pro-survival genes (i.e., Xiap, Bcl-XL) (Lee 
et al., 2009).   
The significance of an early ethanol-mediated up-regulation of genes encoding 
antioxidant enzymes and/or anti-apoptotic factors may represent an attempt of fetal 
rhombencephalic neurons to defend themselves against the pro-apoptotic effects of 
ethanol.  For example, XIAP is an inhibitor of the apoptotic enzyme caspase-3 (Salvesen 
and Duckett, 2002), and Bcl-XL would stabilize the mitochondria, the epicenter of 
ethanol-mediated cell damage, from releasing cytochrome C.  Moreover, increased 
mitochondrial SOD2 stabilizes mitochondria by neutralizing O2•- to hydrogen peroxide, 
which is further reduced to water by catalase (Song and Lee, 2003; Temple et al., 2005; 
Wheeler et al., 2001).  Therefore, SOD and catalase could potentially attenuate ethanol-
associated oxidative stress, i.e., O2•- and hydrogen peroxide production, and the 
associated apoptosis.  Alternatively, it is possible that the ethanol-mediated early increase 
in catalase might contribute to the neuron’s efforts to metabolize ethanol.  However, the 
toxic product, acetaldehyde, is not further metabolized, this could damage the developing 
brain (Lee et al., 2005).   
Although the mechanism by which ethanol exposure initially increased the 
expression of Sod2 and catalase genes has not been confirmed, it could involve the rapid 
rise in ROS which accompanies ethanol exposure (Ramachandran et al., 2003; Watts et 
al., 2005).  An increase in cellular ROS can activate several classes of genes, including 
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those that are dependent on NF-κB (Ji et al., 2004; Turpaev, 2002; Zhou et al., 2001a) 
and Nrf2 (Zhu et al., 2005), which binds to the antioxidant response element (ARE) 
[reviewed by (Kensler et al., 2007)].  Catalase as well as XIAP and Bcl-XL can be 
regulated by NF-κB dependent mechanisms (Kucharczak et al., 2003; Zhou et al., 2001a).  
Catalase and SOD also can be regulated Nrf2 (Zhu et al., 2005).  Thus, it is likely that the 
early ethanol-associated augmentation of gene expression is mediated by increased ROS 
on ROS-sensitive transcription factors.  Consistent with this explanation, microarray 
studies show that ethanol upregulates additional CNS genes that are known to be induced 
by oxidative stress (Treadwell and Singh, 2004). 
 
Late response to ethanol 
Although the early ethanol-associated rise in catalase and Sod2 are accompanied 
or followed by an increase in enzyme activity, these potentially protective effects are 
transient.  Expression of Sod1 in ethanol-treated neurons returns to levels in 
control/unstressed neurons by 48 hours; catalase falls by 24 hours.  In both cases, 
enzyme activity was comparable to levels in unstressed neurons.  In fact, with the 
exception of the mentioned early rise and a later rise of Sod1 and Sod2 expression (but 
not activity) at 24 hours, the expression of the Sod and catalase genes and the associated 
enzyme activities was comparable to that in unstressed/control neurons at other times. 
Temporal and brain region specific effects of ethanol on the SOD and catalase 
enzymes were previously reported (Heaton et al., 2003a; Heaton et al., 2003b; Heaton et 
al., 2003c).  Although the levels of antioxidant enzymes at 24 and 48 hours might be 
suitable for unstressed neurons, it is doubtful they are sufficient to counteract the 
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damaging effects of oxidative stress.  Consequently, the ethanol-treated neurons may not 
be able to combat the effects of increased ROS for more than a brief time.  Although we 
did not detect an ethanol-associated reduction in SOD activity in our in vitro studies, 
lower SOD activity was found in brain following in utero exposure to ethanol (Ledig et 
al., 1981).   
We cannot eliminate the possibility that the ethanol-mediated increase in Sod1 
and Sod2 at 24 hours is accompanied by augmented activity of SOD at a time between 24 
and 48 hours, which was not examined in this study.  Such changes could exacerbate the 
oxidative stress by overproducing hydrogen peroxide.  Oxidative stress could develop 
because the ethanol-treated neurons do not have a corresponding increase in catalase 
expression or activity at that time, and catalase would be necessary to convert hydrogen 
peroxide to water.   
It is curious that there was an ethanol-associated increase in Sod1 and Sod2 at 24 
hours when many cells had already undergone apoptosis.  At present, we do not have an 
explanation for this second rise in the expression of these genes.  It is possible that the 
secondary increase in Sod1 and Sod2 represents another attempt of surviving neurons to 
resist the damaging effects of ethanol, and that this was mediated by increased ROS.  
However, such an attempt would have been futile since there does not appear to be a 
corresponding increase in SOD activity.   
This laboratory also reported that an initial ethanol-associated rise in Xiap and 
Bcl-XL (Lee et al., 2009) is followed by a decline to subnormal levels.  Similarly, Ciap1, 
Ciap2, and Bcl-2 were subnormal after a 24-hour exposure to ethanol (Druse et al., 2006).  
The similar timing of the reduced expression of pro-survival genes and inappropriately 
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low expression of genes that encode antioxidant enzymes correlate with augmented 
apoptosis (Druse et al., 2005; Druse et al., 2004; Druse et al., 2007) and with reduced 
activity of the PI3KpAkt pro-survival pathway (Druse et al., 2005).   
 
Early response to ipsapirone 
As noted previously, ipsapirone prevented the early ethanol-mediated increase in 
catalase expression.  This implies a possible role of ipsapirone to mediate regulation of 
catalase expression.  Because catalase is the major enzyme to metabolize ethanol in rat 
brain (Zimatkin et al., 2006), an early increase in catalase might augment ethanol 
metabolism.  Such an effect could help reduce the damaging direct effects of ethanol.  
However, it would also have the potential to increase toxic acetaldehyde levels, unless 
this compound were efficiently degraded to acetate (Giavini et al., 1992; Lee et al., 
2005).   
Although the signaling mechanism by which ipsapirone influences the expression 
of catalase, Sod1 and Sod2 in control or ethanol-treated neurons is not known, it could 
involve receptor-mediated activation of the PI3K  pAkt pro-survival pathway, which 
reportedly regulates the expression of SOD1 (Rojo et al., 2004).   
At two time points, 2 and 48 hours, there was a significant interaction between 
ethanol and ipsapirone, which resulted in decreased Sod1 in the ethanol plus ipsapirone 
treatment group.  The change at the latter time point corresponded with reduced activity 
of SOD.  As noted, SOD is involved with the detoxification of ROS by catalyzing a 
reaction which forms hydrogen peroxide.  Normally, catalase would further detoxify this 
species of ROS by converting it to water.  At present, it is not known whether the reduced 
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SOD attenuates oxidative stress by lowering the production of hydrogen peroxide or 
whether it augments oxidative stress by limiting the detoxification of superoxide anion.   
In addition, the mechanism by which the combined effects are mediated is not clear, but 
it might involve crosstalk between ethanol-mediated (involving ROS) and receptor-
mediated Sod1 expression.   
 
Late response to ipsapirone 
At later critical time points, ipsapirone exerted potentially neuroprotective effects 
on ethanol-treated neurons.  In fact, at times when ethanol significantly reduced XIAP 
and/or Bcl-XL, i.e., (16-48 hours), co-treatment with ipsapirone either brought the 
expression of these genes back to control levels or significantly increased expression 
above the levels in ethanol-treated or control neurons (Lee et al., 2009).  In addition, 
ipsapirone upregulated catalase expression at 24 hours and activity by 48 hours.  
Augmented expression of the NF-κB-dependent genes XIAP and Bcl-XL in ethanol-treated 
neuronal cultures appears to be related to the ability of ipsapirone to increase PI3K  
pAkt (Druse et al., 2006), because the PI3K inhibitor LY 294002 blocked the ipsapirone-
mediated increase.  An investigation of the effects of the PI3K inhibitor on catalase is 
discussed in a subsequent chapter.  It should also be noted that the timing of the 
ipsapirone-mediated increases in Xiap, Bcl-XL, Sod1, Sod2, and catalase were not 
identical, suggesting the possibility that multiple transcription factors participate in the 
regulation of these genes (Ji et al., 2004; Kucharczak et al., 2003; Turpaev, 2002; Zhou et 
al., 2001a; Zhu et al., 2005). 
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 It is likely that ipsapirone’s ability to block an ethanol-associated decrease in the 
expression of anti-apoptotic genes or augment such expression is meaningful biologically 
because ipsapirone treatment also blocked ethanol-associated apoptosis at 24 hours 
(Druse et al., 2005; Druse et al., 2004).  It is unlikely that the ipsapirone-mediated 
elevation of catalase activity at 48 hours can explain ipsapirone’s anti-apoptotic effects at 
24 hours.  However, this change could contribute to the neuroprotective effects that are 
observed when ipsapirone is co-administered with ethanol on a more prolonged basis (> 
24 hours).  For example, the catalase changes might contribute to ipsapirone-mediated 
neuroprotection found in vivo when ethanol-treated pregnant dams are treated with this or 
a related drug during the latter portion of gestation (Tajuddin and Druse, 1999; Tajuddin 
and Druse, 2001).  Consistent with this hypothesis, a 24-hour co-treatment with catalase 
reduced the ethanol-associated increase in ROS and protected from ethanol-mediated cell 
death in PC12 cells (Li et al., 2001a).   
In contrast to the evidence that ipsapirone’s neuroprotective effects might be 
linked with the up-regulation of anti-apoptotic/pro-survival genes and increased 
expression and activity of catalase, it does not appear that changes in Sod1 and Sod2 
contribute to these effects.   In fact, the only times when there was either a main effect of 
ipsapirone or an interaction of the effects of ipsapirone and ethanol were at 2 and 48 
hours for both SOD genes.  However, ipsapirone decreased Sod1 at both times in ethanol-
treated neurons.  In addition, the ipsapirone-mediated increase in Sod1 in control neurons 
did not attenuate apoptosis under basal conditions (Druse et al., 2004).  Regarding Sod2, 
both ipsapirone and ethanol increased gene expression at 2 hours and these effects were 
not additive.  Although Sod2 was increased in the ethanol plus ipsapirone group at the 48-
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hour time point, SOD enzyme activity was actually reduced at that time.  Nonetheless, we 
cannot rule out the possibility that the increased Sod2 at 48 hours led to an increase in 
SOD activity at a later time 
 Although ipsapirone significantly increased catalase, Sod1, and Sod2 in control 
neurons, these changes were not followed by increased enzyme activity.  Similarly, 
ipsapirone-mediated increases in the expression of Xiap and Bcl-XL in control neurons did 
not augment survival in these neurons (Druse et al., 2005; Druse et al., 2004).  Evidently, 
there are cellular compensatory mechanisms in control neurons which prevent 
overproduction of certain molecules. 
 
Protective effects of EUK-134 
 Many investigators previously demonstrated the protective effects of EUK-134 
against different diseases (Chen et al., 2004; Pong et al., 2001; Rong et al., 1999; Samai 
et al., 2007).  Particularly, EUK-134 prevented limb malformations induced by ethanol 
exposure during the gestational period (Chen et al., 2004). Evidence that this synthetic 
SOD/catalase mimetic reduced ethanol-associated apoptosis suggests that ethanol-
induced apoptosis is associated with oxidative stress, and that endogenous antioxidant 
enzymes such as SOD and catalase can exert neuroprotective effects against the 
damaging effects of ethanol.  
It is important to note that there was gradually increasing apoptosis (though not 
significantly different) in cultures with higher concentrations of EUK-134 even in the 
absence of ethanol.  Such effects might be caused due to antioxidant-mediated pro-
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oxidizing cellular status after introducing high concentrations of antioxidants [reviewed 
in (Halliwell, 2000)]. 
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Figure 19.  Ipsapirone increases Sod1 mRNA in fetal rhombencephalic neurons at 
2 hours.  Each value represents the mean ± the SEM of values obtained from 4 to 6 
separate experiments.  Values are expressed as the fold change in mRNA as calculated 
by the 2 -ΔΔCT method.  Values that are significantly different from the time-matched 
control (no ethanol, no ipsapirone) value at p < .05 are represented by the *.  The # 
identifies values that are significantly different from the time-matched ipsapirone 
value at p < .05. 
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol x Ipsapirone Interaction: F (1,18) = 15.45, p < .01 
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Figure 20.  Ethanol and co-treatment increases Sod1 mRNA in fetal 
rhombencephalic neurons at 24 hours.  Each value represents the mean ± the SEM 
of values obtained from 3 to 4 separate experiments.  Values are expressed as the fold 
change in mRNA as calculated by the 2 -ΔΔCT method.  Values that are significantly 
different from the time-matched control (no ethanol, no ipsapirone) value at p < .01 
are represented by the **.  The ## identifies values that are significantly different from 
the time-matched ipsapirone value at p < .01. 
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,13) = 42.4, p < .01 
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Figure 21.  Co-treatment decreased Sod1 mRNA in fetal rhombencephalic 
neurons at 48 hours.  Each value represents the mean ± the SEM of values obtained 
from 4 to 5 separate experiments.  Values are expressed as the fold change in mRNA 
as calculated by the 2 -ΔΔCT method.  Values that are significantly different from the 
time-matched control (no ethanol, no ipsapirone) value at p < .05 are represented by 
the *.  The # identifies values that are significantly different from the time-matched 
ipsapirone value at p < .05. 
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,17) = 10.3, p < .01 
Ethanol x Ipsapirone Interaction: F (1,17) = 4.4, p < .05 
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Figure 22.  The effects of ethanol and ipsapirone on Sod1 mRNA expression over 
time.  Each value represents the mean ± the SEM of values obtained from 3 to 6 
separate experiments: Control (clear), Ipsapirone (dotted), Ethanol (dark), and Ethanol 
+ Ipsapirone (gray).  Values are expressed as the fold change in mRNA as calculated 
by the 2 -ΔΔCT method.  Values that are significantly different from the time-matched 
control (no ethanol, no ipsapirone) value at p < .05 and p < .01 are represented by the 
* and **, respectively.  The # and ## identifies values that are significantly different 
from the time-matched ipsapirone value at p < .05 and p < .01, respectively. 
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
2 hours -   Ethanol x Ipsapirone Interaction: F (1,18) = 15.45, p < .01 
24 hours - Ethanol: F (1,13) = 42.4, p < .01 
48 hours - Ethanol: F (1,17) = 10.3, p < .01 
       Ethanol x Ipsapirone Interaction: F (1,17) = 4.4, p < .05 
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Figure 23.  Scatter plot showing the effects of ethanol and ipsapirone on Sod1 
mRNA over time.  Each value represents the mean ± the SEM of values obtained 
from 4 to 11 separate experiments: Control (flat), Ipsapirone (circle), Ethanol 
(triangle), and Ethanol + Ipsapirone (square).  Values are expressed as the fold change 
in mRNA as calculated by the 2 -ΔΔCT method.  Values that are significantly different 
from the time-matched control (no ethanol, no ipsapirone) value at p < .05 and p < .01 
are represented by the * and **, respectively.  The # and ## identifies values that are 
significantly different from the time-matched ipsapirone value at p < .05 and p < .01, 
respectively. 
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Figure 24.  Ipsapirone, Ethanol, and co-treatment increased Sod2 mRNA in fetal 
rhombencephalic neurons at 2 hours.  Each value represents the mean ± the SEM of 
values obtained from 10 separate experiments.  Values are expressed as the fold 
change in mRNA as calculated by the 2 -ΔΔCT method.  Values that are significantly 
different from the time-matched control (no ethanol, no ipsapirone) value at p < .05 
and p < .01 are represented by the * and **, respectively.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,35) = 7.10, p < .05 
Ethanol x Ipsapirone Interaction: F (1,35) = 8.82, p < .01 
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Figure 25.  Ethanol and co-treatment increased Sod2 mRNA in fetal 
rhombencephalic neurons at 24 hours.  Each value represents the mean ± the SEM 
of values obtained from three to 4 separate experiments.  Values are expressed as the 
fold change in mRNA as calculated by the 2 -ΔΔCT method.  Values that are 
significantly different from the time-matched control (no ethanol, no ipsapirone) value 
at p < .05 is represented by the *.  
 
  
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,15) = 10.9, p < .01 
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Figure 26.  Co-treatment increased Sod2 mRNA in fetal rhombencephalic 
neurons at 48 hours.  Each value represents the mean ± the SEM of values obtained 
from 5 separate experiments.  Values are expressed as the fold change in mRNA as 
calculated by the 2 -ΔΔCT method.  Values that are significantly different from the time-
matched control (no ethanol, no ipsapirone) value at p < .05 are represented by the *.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ipsapirone: F (1,18) = 5.13, p < .05 
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Figure 27.  The effects of ethanol and ipsapirone on mitochondrial Sod2 mRNA 
expression over time.  Each value represents the mean ± the SEM of values obtained 
from 4 to 11 separate experiments: Control (clear), Ipsapirone (dotted), Ethanol (dark), 
and Ethanol + Ipsapirone (gray).  Values are expressed as the fold change in mRNA as 
calculated by the 2 -ΔΔCT method.  Values that are significantly different from the time-
matched control (no ethanol, no ipsapirone) value at p < .05 and p < .01 are 
represented by the * and **, respectively.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
2 hours - Ethanol: F (1,35) = 7.10, p < .05 
     Ethanol x Ipsapirone Interaction: F (1,35) = 8.82, p < .01 
 24 hours - Ethanol: F (1,15) = 10.9, p < .01 
48 hours - Ipsapirone: F (1,18) = 5.13, p < .05 
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Figure 28.  Scatter plot showing the effects of ethanol and ipsapirone on 
mitochondrial Sod2 mRNA over time.  Each value represents the mean ± the SEM 
of values obtained from 4 to 11 separate experiments: Control (flat), Ipsapirone 
(circle), Ethanol (triangle), and Ethanol + Ipsapirone (square).  Values are expressed 
as the fold change in mRNA as calculated by the 2 -ΔΔCT method.  Values that are 
significantly different from the time-matched control (no ethanol, no ipsapirone) value 
at p < .05 and p < .01 are represented by the * and **, respectively.  
 
121 
 
 
Figure 29.  Ipsapirone increases SOD enzyme activity after 2 hours.  Each value 
represents the mean ± the SEM of values obtained from 4 to 5 separate experiments.  
Values are expressed as the fold change in SOD enzyme activity (U/mL•µg).  Values 
that are significantly different from the time-matched control (no ethanol, no 
ipsapirone) value at p < .05 are represented by the *.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol x Ipsapirone Interaction: F (1,18) = 7.9, p < .05 
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Figure 30.  Co-treatment decreases SOD enzyme activity after 48 hours.  Each 
value represents the mean ± the SEM of values obtained from 4 separate experiments.  
Values are expressed as the fold change in SOD enzyme activity (U/mL•µg).  Values 
that are significantly different from the time-matched control (no ethanol, no 
ipsapirone) value at p < .05 are represented by the *.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,15) = 9.13, p < .01 
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Figure 31.  The effects of ethanol and ipsapirone on SOD enzyme activity over 
time. Each value represents the mean ± the SEM of values obtained from 3 to 6 
separate experiments: Control (clear), Ipsapirone (dotted), Ethanol (dark), and Ethanol 
+ Ipsapirone (gray).  Values are expressed as the fold change in SOD enzyme activity 
(U/mL•µg).  Values that are significantly different from the time-matched control (no 
ethanol, no ipsapirone) value at p < .05 are represented by the *.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
2 hours - Ethanol x Ipsapirone Interaction: F (1,18) = 7.90, p < .05 
48 hours - Ethanol: F (1,15) = 9.13, p < .01 
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Figure 32.  Ethanol increases catalase mRNA in fetal rhombencephalic neurons 
at 8 hours.  Each value represents the mean ± the SEM of values obtained from 3 to 5 
separate experiments.  Values are expressed as the fold change in mRNA as calculated 
by the 2 -ΔΔCT method.  Values that are significantly different from the time-matched 
control (no ethanol, no ipsapirone) value at p < .05 are represented by the *.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ipsapirone: F (1,15) = 8.59, p < .05 
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Figure 33.  Ipsapirone and co-treatment increased catalase mRNA in fetal 
rhombencephalic neurons at 24 hours.  Each value represents the mean ± the SEM 
of values obtained from 6 to 7 separate experiments.  Values are expressed as the fold 
change in mRNA as calculated by the 2 -ΔΔCT method.  Values that are significantly 
different from the time-matched control (no ethanol, no ipsapirone) value at p < .05 
and p < .01, are represented by the * and **, respectively.  The ¶ and ¶¶ identifies 
values that are significantly different from those in the ethanol group (p<.05 and 
p<.01, respectively). 
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,24) = 5.75, p < .05   
Ipsapirone: F (1,24) = 35.9, p < .01 
Ethanol x Ipsapirone Interaction: F (1,24) = 4.31, p < .05 
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Figure 34.  The effects of ethanol and ipsapirone on catalase mRNA over time.  
Each value represents the mean ± the SEM of values obtained from 3 to 7 separate 
experiments: Control (clear), Ipsapirone (dotted), Ethanol (dark), and Ethanol + 
Ipsapirone (gray).  Values are expressed as the fold change in mRNA as calculated by 
the 2 -ΔΔCT method.  Values that are significantly different from the time-matched 
control (no ethanol, no ipsapirone) value at p < .05 and p < .01 are represented by the 
* and **, respectively.  The ¶ and ¶¶ identifies values that are significantly different 
from those in the ethanol group (p<.05 and p<.01, respectively). 
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
8 hours - Ipsapirone: F (1,15) = 8.59, p < .05 
24 hours - Ethanol: F (1,24) = 5.75, p < .05   
        Ipsapirone: F (1,24) = 35.9, p < .01 
                   Ethanol x Ipsapirone Interaction: F (1,24) = 4.31, p < .05 
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Figure 35.  Scatter plot showing the effects of ethanol and ipsapirone on catalase 
mRNA over time.  Each value represents the mean ± the SEM of values obtained 
from 4 to 11 separate experiments: Control (flat), Ipsapirone (circle), Ethanol 
(triangle), and Ethanol + Ipsapirone (square).  Values are expressed as the fold change 
in mRNA as calculated by the 2 -ΔΔCT method.  Values that are significantly different 
from the time-matched control (no ethanol, no ipsapirone) value at p < .05 and p < .01 
are represented by the * and **, respectively.  The ¶ and ¶¶ identifies values that are 
significantly different from those in the ethanol group at p<.05 and p<.01, 
respectively. 
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Figure 36.  Ethanol increases catalase enzyme activity after 18 hours.  Each value 
represents the mean ± the SEM of values obtained from 5 to 6 separate experiments.  
Values are expressed as the fold change in catalase enzyme activity (U/mL•µg).  
Values that are significantly different from the time-matched control (no ethanol, no 
ipsapirone) value at p < .05 are represented by the *.  
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,21) = 4.3, p < .05 
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Figure 37.  Co-treatment increases catalase enzyme activity in ethanol-treated 
neurons at 48 hours.  Each value represents the mean ± the SEM of values obtained 
from 3 to 5 separate experiments.  Values are expressed as the fold change in catalase 
enzyme activity (U/mL•µg).  Values that are significantly different from the time-
matched control (no ethanol, no ipsapirone) value at p < .05 are represented by the *.  
The # identifies values that are significantly different from the time-matched 
Ipsapirone value at p < .05. 
 
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,17) = 11.6, p < .01 
Ipsapirone: F (1,17) = 5.9, p < .05 
Ethanol x Ipsapirone Interaction: F (1,17) = 4.8, p < .05 
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Figure 38.  The effects of ethanol and ipsapirone on catalase enzyme activity over 
time. Each value represents the mean ± the SEM of values obtained from 3 to 6 
separate experiments: Control (clear), Ipsapirone (dotted), Ethanol (dark), and Ethanol 
+ Ipsapirone (gray).  Values are expressed as the fold change in SOD enzyme activity 
(U/mL•µg).  Values that are significantly different from the time-matched control (no 
ethanol, no ipsapirone) value at p < .05 are represented by the *.  The # identifies 
values that are significantly different from the time-matched Ipsapirone value at p < 
.05. 
 
 
Two-way ANOVA (Ethanol x Ipsapirone): 
18 hours - Ethanol: F (1,21) = 4.3, p < .05 
48 hours - Ethanol: F (1,17) = 11.6, p < .01 
                 Ipsapirone: F (1,17) = 5.9, p < .05 
                  Ethanol x Ipsapirone Interaction: F (1,17) = 4.8, p < .05 
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Figure 39.  Chemical structure of EUK-134.  
 
132 
 
 Figure 40.  Dose-dependent protection by the SOD/catalase mimetic EUK-134 
against ethanol-associated apoptosis.  (A) Hoechst 33342 dye shows blue staining of 
the non-apoptotic and apoptotic nuclei; apoptotic nuclei (condensed or fragmented) 
are indicated with the arrows. (B) The bar graph shows dose-dependent protection by 
EUK-134 from ethanol-induced apoptosis in the fetal neurons.  Each value represents 
the mean ± the SEM of values obtained from 5 to 6 separate experiments. Values that 
are significantly different from the control value at p < .05 and p < .01 are represented 
by the * and **, respectively.  The # and ## identify values in the ethanol + EUK-134 
group that are significantly different from those in the ethanol group (p < .05 and p < 
.01, respectively).  
 
Two-way ANOVA (Ethanol x Ipsapirone) 
Ethanol: F (1,33) = 26.1, p < .01 
Ethanol x Ipsapirone Interaction: F (1,33) = 18.3, p < .01 
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CHAPTER 5 
IPSAPIRONE-ASSOCIATED ENDOGENOUS ANTIOXIDANT GENE 
REGULATION INVOLVES COMMON PRO-SURVIVAL PATHWAYS 
 
ABSTRACT 
 The studies described in Chapter 4 demonstrated that ethanol and ipsapirone 
activate the expression of endogenous antioxidant enzymes, including Cu/Zn-SOD 
(SOD1), Mn-SOD (SOD2), and/or catalase.  The expression of these genes is mediated 
by the transcription factor nuclear factor-κB (NF-κB) (Rojo et al., 2004; Sompol et al., 
2006; Zhou et al., 2001b).  Also, previous findings from this laboratory suggest that one 
of the neuroprotective effects of the 5-HT1A agonist ipsapirone is linked to activation of 
the phosphoinositide 3-kinase (PI-3K)  pAkt pro-survival pathway and downstream 
upregulation of NF-κB dependent pro-survival genes (Druse et al., 2006; Lee et al., 
2009).  There is also evidence that stimulation of the 5-HT1A receptor activates mitogen-
activated protein kinase (MAPK) pathway (Adayev et al., 1999), another pro-survival 
pathway that can activate NF-κB (Abdouh et al., 2004).  The current study examined the 
potential involvement of the PI-3K and MAPK pathways in the ethanol- and/or 
ipsapirone-induced activation of NF-κB dependent endogenous antioxidant genes, which 
occurs after two hours of treatment.  The results demonstrate that the early/2-hour 
ipsapirone-associated upregulation of Sod1 was inhibited by both LY294002 and 
PD98059, inhibitors of PI-3K and MAPKK, respectively.  Upregulation of Sod2 by 
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ethanol and/or ipsapirone at 2 hours was also inhibited by the two inhibitors. Thus, it 
appears that the augmented expression of the genes that encode NF-κB dependent 
endogenous antioxidant enzymes by ethanol and/or ipsapirone is mediated by the PI-3K 
and MAPK pro-survival pathways.  
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INTRODUCTION 
 Two major signaling pathways that exert pro-survival signals and provide 
protection against cell death, include the PI-3K and MAPK pathways.  Ipsapirone-
mediated activation of the PI-3K pathway protected developing neurons against ethanol 
toxicity (Druse et al., 2005).  The MAPK pathway is also linked with promoting survival 
(Adayev et al., 1999).  Importantly, serotonin-1A agonists activate both of these pro-
survival signaling pathways (Adayev et al., 1999; Cowen et al., 1997; Hsiung et al., 
2005).  In addition, the protective effects of vitamin E against neuronal oxidative stress 
and cell death also appear to involve the activation of both pathways (Numakawa et al., 
2006). Upon activation, these pathways can converge at one common downstream 
effector that is subsequently activated to mediate a pro-survival signal.  Transcription 
factor NF-κB could be such a signal-converging downstream effector, because both the 
MAPK and PI-3K pathways activate NF-κB (Dhandapani et al., 2005; Norris and 
Baldwin, 1999; Schouten et al., 1997).  Thus, activation of the 5-HT1A receptor could 
initiate the signaling cascade that ultimately activates NF-κB (Abdouh et al., 2004; 
Appert-Collin et al., 2005; Dhandapani et al., 2005; Rojo et al., 2004).   
 As discussed in the literature review (Chapter II), there are several pro-survival 
genes that can be transcribed following NF-κB induction, including those that encode for 
endogenous antioxidant enzymes.  In fact, activating NF-κB results in upregulation of 
three major antioxidant enzymes, Cu/Zn-superoxide (SOD1), Mn-SOD (SOD2), and 
catalase (Furukawa et al., 1997; Sompol et al., 2006; Zhou et al., 2001b).  Evidence from 
this and other laboratories suggests that such changes might exert neuroprotection.  One 
study suggested that high constitutive NF-κB activity provided neuronal resistance to 
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hydrogen peroxide-mediated oxidative stress (Lezoualc'h et al., 1998).  It is possible that 
the increased NF-κB resulted in a heightened activation of endogenous antioxidants that 
provided resistance to oxidative stress.   
 The studies described in Chapter IV demonstrate that there is early upregulation of 
SOD1 and SOD2 by ethanol and ipsapirone.  Those studies also show that ethanol-
induced neuronal apoptosis is prevented by a drug that mimics the effects of SOD and 
catalase. The current study investigated two potential signaling pathways that might be 
involved in the early activation of the endogenous antioxidant genes Sod1 and Sod2 by 
ethanol and/or ipsapirone.  The PI-3K and MAPK pathways were the focus of this 
investigation, because they are reportedly linked to 5-HT1A receptor activation and to 
downstream activation of NF-κB; NF-κB subsequently augments expression of the genes 
that encode Sod1 and Sod2. 
 
MATERIALS AND METHODS 
In vitro fetal rhombencephalic neuronal cultures  
The methods used in this study were described previously in several earlier 
publications from this laboratory (Druse et al., 2005; Druse et al., 2004; Druse et al., 
2006; Druse et al., 2007).  All animal care and use procedures were reviewed and 
approved by the Institutional Animal Care and Use Committee at Loyola University 
Chicago, Stritch School of Medicine.  The fetal rhombencephalon, which contains the 
developing 5-HT neurons (Konig et al., 1988), was removed  (Eriksen et al., 2002) from 
timed-pregnant Sprague-Dawley rats (175-185 grams) at gestation day 14 (G14), where 
G=0 corresponds to the day of insemination.  Throughout the dissection procedure, tissue 
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samples were kept ice-cold in Hank’s balanced buffered solution (HBSS), and sterile 
instruments and techniques were used.  Rhombencephalic tissue was mechanically 
disaggregated before seeding onto poly-D-lysine coated plates (Corning, Corning, New 
York) at a density of 8x106 cells/plate (55 cm2).  Cultures were maintained in a neuron-
specific chemically modified media (CMM) that included Dulbecco’s Minimal Essential 
Media/F12 (DMEM/F12) media (Invitrogen, Carlsbad, CA), hydrocortisone-21 sulfate 
(Sigma, St. Louis, MO), Basal Medium Eagle Vitamin Solution (Sigma, St. Louis, MO), 
antibacterial agent gentamicin sulfate (Honegger and Monnet-Tschudi, 1997), B27 
serum-free medium supplement (Invitrogen, Carlsbad, CA) (Brewer et al., 1993), and 
0.25% fetal bovine serum (FBS) (Druse et al., 2004).  After 24 hours, 0.4 µM cytosine 
arabinoside (Sigma, St. Louis, MO) was added to arrest gliogenesis.  
Immunohistochemistry was performed using an antibody to glial fibrillary acidic protein 
(GFAP) to assess the contribution of astrocytes to the cultures; this method confirmed 
that astrocytes comprised < 5% of the cells in these neuronally-enriched cultures.  Cells 
were grown in control media (no ethanol) for 5 days, with media changes made on 
alternate days.  
 
Treatments 
The fetal rhombencephalic neurons were cultured according to the described 
method until DIV 5, when 2-hour treatments with ethanol and/or ipsapirone and or 
enzyme inhibitors were initiated.  Using an ethanol chamber system described by this 
laboratory (Druse et al., 2004), cultures were divided into four groups for RNA isolation 
and enzyme activity assays.  The four treatment groups were Control (no ipsapirone/no 
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ethanol), Ipsapirone (100 nM ipsapirone), Ethanol (50 mM ethanol), and Ethanol + 
Ipsapirone (co-treatment with 50 mM ethanol + 100 nM ipsapirone).  In addition, either 
LY294002 (PI-3K inhibitor) or PD98059 (MAPKK inhibitor) were included in samples 
from each of the treatment groups.  The concentration of ipsapirone used in this project 
promotes the development of 5-HT neurons (Whitaker-Azmitia et al., 1990) and prevents 
apoptosis in fetal rhombencephalic neurons (Druse et al., 2004).    
 
RNA Isolation and cDNA Synthesis 
 Trizol reagent (Life Technology, Gaithersburg, MD) (Druse et al., 2006; Druse et 
al., 2007; Lee et al., 2009) was used to extract total RNA from cultured fetal 
rhombencephalic neurons.  Glycogen (20 mg/ml) (Ambion, Austin, TX) was included to 
facilitate the precipitation of RNA and to maximize the yield of RNA.  RNA was 
dissolved in 25 µl DEPC-treated H2O, which was treated with DNA-free (Ambion, 
Austin, TX) to remove contaminating genomic DNA.  RNA was stored at –80o until use.  
Single strand cDNA was synthesized from 1 to 2 µg of total RNA (DNA-free) using the 
First Strand cDNA synthesis kit (Fermantas, Hanover, MD). 
 
Quantitative real-time RT-PCR 
           cDNA (DNA equivalent of 20 ng to 40 ng of total RNA) was diluted with 
Platinum Quantitative PCR Super Mix-UDG [1.5 U Platinum Taq DNA polymerase, 20 
mM Tris-HCl (pH 8.4), 50 mM KCl, 3 mM MgCl2, 200 mM dGTP, 200 mM dATP, 200 
mM dCTP, 400 mM dUTP, 1 U UDG (Life Technology)], 0.25 mM Rox  (Life 
Technology), 1/40,000 SYBR Green (Molecular Probes, Eugene, Oregon), and primers 
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(Druse et al., 2006; Lee et al., 2009).  A Perkin-Elmer Gene Amp 7300 Sequence 
Detector thermal cycler (Applied Biosystems, Foster City, CA) was used for PCR 
amplifications.  RT-PCR data was analyzed using SDS software (Applied Biosystems).  
Sample inputs were normalized using GAPDH.   
 Plasmid containing target genes were used to generate standard curves for real-
time quantitative RT-PCR assays (Druse et al., 2006), and a standard curve was generated 
from serial dilutions of known amounts of the input copy number of target genes.  
Standard curves for GAPDH and genes of interest (10-100,000 copies/µl) were 
performed in each experiment.  Routinely, we included a triplicate RT-PCR reaction 
lacking cDNA or known DNA template for each set of primers.  Specific primary 
sequences for Sod, Sod2, catalase (Chapter 4) and GAPDH were selected using the 
Primer Express program (Applied Biosystems) and sequences available from the NCBI 
database.  Primers were synthesized by Life Technology.  The forward (F) and reverse 
(R) primer sequences for rat genes are included in Table 2.  Typically, GAPDH and the 
three target genes were first detected at 22 or 28 cycles, respectively. As previously 
described (Druse et al., 2006; Druse et al., 2007), data were analyzed using the 2-∆∆CT 
method (Livak and Schmittgen, 2001).   
 
Statistical analyses 
 Data were analyzed using two-way ANOVA and a post-hoc Newman-Keuls 
procedure to test our hypotheses that LY294002 and PD98059 treatment alters the 
expression of some NF-κB dependent survival genes in ethanol and/or ipsapirone-treated 
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neurons to levels found in untreated (control) cultures. A p value < .05 was considered to 
be significant. 
 
RESULTS 
Early upregulation of Sod1 and Sod2 is mediated by the PI-3K and MAPK pathways 
 Inclusion of the PI-3K inhibitor LY294002 with the treatment groups blocked the 
ipsapirone-associated increase in Sod1 at 2 hours (p < .01) (Figure 41).  The MAPKK 
inhibitor PD98059 also prevented (p < .01) upregulation of Sod1 at 2 hours (Figure 42).  
In similar investigations of the Sod2 gene, LY294002 blocked the upregulation of Sod2 
found in cultures treated with ethanol, ipsapirone, or ethanol plus ipsapirone Sod2 (p < 
.01) (Figure 43).  Moreover, the MAPKK inhibitor PD98059 prevented the upregulation 
of Sod2 after a 2-hour treatment of ipsapirone (p < .05), ethanol (p < .01), and co-
treatment of ethanol and ipsapirone (p < .05) (Figure 44).   
 
DISCUSSION 
The present study determined that early ethanol and/or ipsapirone-induced 
expression of Sod1 and Sod2, demonstrated in this and the previous chapter, was 
regulated by PI-3K and MAPK, because inhibitors of these pathways blocked the effects 
of ethanol and/or ipsapirone.  Previously, 5-HT1A receptor stimulation was shown to 
activate PI-3K and MAPK (Adayev et al., 1999; Druse et al., 2005), augment the effects 
of NF-κB (Dhandapani et al., 2005; Norris and Baldwin, 1999), and promote survival 
(Adayev et al., 1999; Hsiung et al., 2005).  Also, this laboratory reported that the 
ipsapirone augments the expression of other NF-κB-dependent pro-survival genes, i.e., 
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XIAP and Bcl-XL, and that these changes correlate temporally with neuronal protection 
against ethanol-induced apoptosis (Druse et al., 2006; Lee et al., 2009). 
An interesting finding in this study was that the ethanol-mediated increase in 
SOD2 expression was inhibited by both LY294002 and PD98059.  One mechanism by 
which ethanol might activate PI-3K and MAPK could involve the rapid rise in ROS.  
Chapter 3 described the increase in ROS, which begins immediately after ethanol is 
added to cultures.  Consistent with this possibility, Han et al. showed that PI-3K and 
MAPK are activated by pre-conditioning with a low concentration of hydrogen peroxide; 
this pre-conditioning also leads to cell survival (Han et al., 2001).  Another possible 
mechanism by which ethanol can activate signaling pathways is through its actions on 
membrane proteins.  In fact, there is evidence that ethanol acts indirectly to activate or 
inhibit membrane receptors in the CNS.  Such receptors include the glutamate receptor 
and gamma-aminobutyric acid type A (GABAA) receptor (Lovinger et al., 1989).  
Ethanol also inhibits the adenosine transporter in rat hippocampus (Diao and Dunwiddie, 
1996), thereby increasing the available adenosine to bind to its receptors.  Indeed, the A1-
adenosine receptor can activate PI-3K (Germack and Dickenson, 2000).  Interestingly, a 
low concentration of ethanol (2 to 20 mM) activates the PI-3K and MAPK pathways, and 
induces subsequent activation of NF-κB.  The same study also suggested that ethanol 
activates MAPK in PI-3K dependent manner (Liu et al., 2002). 
In summary, it appears that the early effects of ethanol and ipsapirone both 
involve activation of the PI-3K and MAPK pathways.  The effects of ipsapirone are 
likely mediated by the 5-HT1A receptor, which has been linked to both pathways.  In 
contrast, the effects of ethanol are likely to involve the ethanol-associated increase in 
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ROS and the ROS-sensitivities of both pathways.  Whether similar effects of ethanol also 
occur in vivo are not yet known.  It is possible that the low serum concentration used in 
this study made our neuronal cultures particularly sensitive to oxidative stress (Chan et 
al., 2001).  In addition, although the inhibitor studies strongly suggested that both the PI-
3K and MAPK pathways are involved in the early activation of Sod1 and/or Sod2 by 
ethanol or ipsapirone, the effects of these inhibitors are not 100% selective.  Thus, 
additional studies would help to confirm the specific involvement of these enzymes with 
the effects of ipsapirone and ethanol. 
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Figure 41.  The early upregulation of Sod1 after 2-hour ipsapirone treatment was 
inhibited by LY294002, an inhibitor of the PI-3K   pAkt pro-survival pathway.  
Each value represents the mean ± the SEM of values obtained from 3 to 6 separate 
experiments.  Values are expressed as the fold change in mRNA as calculated by the 2 
-ΔΔCT method.  The results of a 2-WAY ANOVA done on the original (no inhibitor) 
data are provided in the legends to Figures 19 to 23.  A 3-WAY ANOVA (ethanol x 
ipsapirone x LY) found an interaction of ethanol x isapirone x LY 
[F(1,31) = 18.6, p < .001].  The results of a post-hoc test are depicted by the following 
notations.  Values that are significantly different from the time-matched control (no 
ethanol, no ipsapirone) value at p < .05 are represented by the *.  The # identifies 
values that are significantly different from the time-matched ipsapirone value at p < 
.05.  The ^ indicates values that are significantly different between treatment versus 
inhibitor at p < .05.   
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Figure 42.  The early upregulation of Sod1 after a 2-hour ipsapirone treatment 
was inhibited by PD98059, an inhibitor of the MAPKK   MAPK pro-survival 
pathway.  Each value represents the mean ± the SEM of values obtained from 3 to 6 
separate experiments.  Values are expressed as the fold change in mRNA as calculated 
by the 2 -ΔΔCT method.  The results of a 2-WAY ANOVA done on the original (no 
inhibitor) data are provided in the legends to Figures 19 to 23.  A 3-WAY ANOVA 
(ethanol x ipsapirone x PD) found an interactions of ethanol x isapirone x PD 
[F(1,24) = 5.6, p < .05].  The results of a post-hoc test are depicted by the following 
notations.  Values that are significantly different from the time-matched control (no 
ethanol, no ipsapirone) value at p < .05 are represented by the *.  The # identifies 
values that are significantly different from the time-matched ipsapirone value at p < 
.05.  The ^ indicates values that are significantly different between treatment versus 
inhibitor at p < .05.   
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Figure 43.  The early upregulation of Sod2 after a 2-hour ipsapirone treatment 
was inhibited by LY294002, an inhibitor of the PI-3K   pAkt pro-survival 
pathway.  Each value represents the mean ± the SEM of values obtained from 3 to 11 
separate experiments.  Values are expressed as the fold change in mRNA as calculated 
by the 2 -ΔΔCT method.  The results of a 2-WAY ANOVA done on the original (no 
inhibitor) data are provided in the legends to Figures 19 to 23.  A 3-WAY ANOVA 
(ethanol x ipsapirone x LY) found a main effect of LY [F(1,51) = 27.2, p < .0001].  
The results of a post-hoc test are depicted by the following notations.  Values that are 
significantly different from the time-matched control (no ethanol, no ipsapirone) value 
at p < .01 and p < .05 are represented by the * and **, respectively.  The ^ and ^^ 
indicate values that are significantly different between treatment versus inhibitor at p < 
.05 and p < .05, respectively. 
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Figure 44.  The early upregulation of Sod2 after a 2-hour ipsapirone treatment 
was inhibited by PD98059, an inhibitor of the MAPKK   MAPK pro-survival 
pathway.  Each value represents the mean ± the SEM of values obtained from 3 to 11 
separate experiments.  Values are expressed as the fold change in mRNA as calculated 
by the 2 -ΔΔCT method.  The results of a 2-WAY ANOVA done on the original (no 
inhibitor) data are provided in the legends to Figures 19 to 23.  A 3-WAY ANOVA 
(ethanol x ipsapirone x PD) found a main effect of PD [F(1,44) = 18.5, p < .0001].  
The results of a post-hoc test are depicted by the following notations.  Values that are 
significantly different from the time-matched control (no ethanol, no ipsapirone) value 
at p < .01 and p < .05 are represented by the * and **, respectively.  The ^ and ^^ 
indicate values that are significantly different between treatment versus inhibitor at p < 
.05 and p < .05, respectively. 
 147 
CHAPTER 6 
SUMMARY AND DISCUSSION 
 
Fetal Rhombencephalic Neurons 
 The rhombencephalon is the primary region of the developing central nervous 
system that contains the cell bodies that give rise to the 5-HT neurons of the raphe nuclei.  
Because the rhomencephalon contains a large population of serotonergic neurons, and 
because ethanol severely damages developing the serotonergic system (Rathbun and 
Druse, 1985; Sari and Zhou, 2004; Tajuddin and Druse, 1999; Zhou et al., 2001a), 
utilization of cultures of fetal rhombencephalic neurons provides a means to study 
possible mechanisms underlying the adverse effects of ethanol on developing serotonin 
system.   Because many of the neurons in these cultures express 5-HT1A receptors (Figure 
11), these cultures also provide a means to study the mechanism by which the 5-HT1A 
agonist exerts its neuroprotective effects. 
 
Ethanol Causes a Rapid Increase and Accumulation of ROS 
In the acute ethanol treatment model, it is likely that oxidative stress results from 
a rapid increase of ROS within the cell.  Consistent with findings from the present study, 
which demonstrated that acute ethanol exposure quickly and progressively increased the 
generation of ROS in cultures of fetal rhombencephalic neurons, another laboratory also 
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demonstrated that in vitro acute ethanol treatment resulted in high levels of ROS within 
30 minutes in the developing cortical neurons (Ramachandran et al., 2003).  Due to 
difficulties in using the ROS detection dye in ethanol-treated cultures for a prolonged 
time, it was not feasible to assess ROS levels in cultures treated with ethanol for 24 
hours.  One complicating factor is the volatility of ethanol in the microplate reader.  
Another complication is the oxidation of the ROS detection dye even in cultures that 
lacked ethanol. Future studies of the prolonged and acute effects of ethanol could 
examine more stable signs of oxidative stress, e.g., levels of oxidized proteins and DNA.  
 
Effects of Ethanol on the Expression of Endogenous Antioxidants 
This study showed an early ethanol-associated increase in Sod2 and catalase 
expression.   Studies using inhibitors suggest that the ethanol-induced increase in Sod2 at 
2 hours was mediated by the PI-3K and MAPK pro-survival pathways.  The early 
increase in Sod2 and catalase could represent an initial attempt for fetal rhombencephalic 
neurons to survive.  Alone, SOD2, a mitochondrial enzyme, detoxifies superoxide, a 
precursor to generating more toxic ROS.  However, because SOD2 and catalase work in 
sequence to detoxify mitochondria-damaging superoxide and hydrogen peroxide, 
respectively (Song and Lee, 2003; Temple et al., 2005; Wheeler et al., 2001), increased 
expression of the two antioxidants could help keep mitochondrion healthy if this 
expression was paralleled by changes in enzyme activity. Although the ethanol-
associated change in Sod2 was not paralleled by a similar change in enzyme activity at 
the times measured in our study, the significant increase in catalase was followed by a 
corresponding elevation in catalase activity.  Importantly, investigations from other 
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laboratories show that an early effect of ethanol was increased expression of SOD and 
catalase in brain (Enache et al., 2008; Heaton et al., 2003a; Heaton et al., 2003b; Heaton 
et al., 2003c; Reddy et al., 1999). 
Additional studies from this laboratory (Lee et al., 2009) also show that an early 
response to ethanol produced increased expression of the genes that encode the anti-
apoptotic proteins Bcl-2 and XIAP.  It is likely that ipsapirone’s ability to block an 
ethanol-associated decrease in the expression of anti-apoptotic genes or augment such 
expression is meaningful biologically, because ipsapirone treatment also blocked ethanol-
associated apoptosis at 24 hours (Druse et al., 2005; Druse et al., 2004).  In a survey of 
potential ethanol responsive genes, researchers found that even a low concentration of 
ethanol (50 mM) causes more genes to be upregulated than down-regulated.  Among the 
upregulated genes are neuronal anti-apoptotic genes.  The review also suggests that the 
regulation their expression might involve ROS (Rahman and Miles, 2001).   
Any potential protective effects of an ethanol-induced upregulation of antioxidant 
gene expression are transient.  By 24 hours catalase expression in ethanol-treated 
neurons returned to levels of those in unstressed control neurons.  Similarly, Sod1 and 
Sod2 returned to control levels by 48 hours.   
There was also a second ethanol-associated rise in Sod1 and Sod2 at 24 hours. 
This happened at a time when many cells had already undergone apoptosis.  At present, 
we do not have an explanation for this second rise in the expression of these genes.  It is 
possible that the secondary increase in Sod1 and Sod2 represents another attempt of 
surviving neurons to resist the damaging effects of ethanol, but it is likely that such an 
attempt would have been futile because there does not appear to be a corresponding 
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increase in SOD activity.  However, we cannot eliminate the possibility that SOD activity 
was augmented at a time between 24 and 48 hours that was not examined in this study.   
Importantly, if these changes were paralleled by changes in enzyme activity, they could 
actually exacerbate the oxidative stress by overproducing hydrogen peroxide.  Oxidative 
stress could develop, because the ethanol-treated neurons do not have a corresponding 
increase in catalase expression or activity at that time, and catalase would be necessary to 
convert hydrogen peroxide to water.  In fact, when Sod is overexpressed in fetal 
hippocampal neurons, there were increased levels of hydrogen peroxide and augmented 
neurotoxicity (Zemlyak et al., 2006).   
 
Pre-Treatment of Ipsapirone Reduces Ethanol-Mediated ROS Accumulation 
Co-treatment with ipsapirone did not prevent the acute ethanol-mediated increases 
in ROS.   These findings strongly suggest that ipsapirone does not as a free radical 
scavenger.   However, when fetal rhombencephalic neurons were pre-treated for 24 hours 
with ipsapirone, this treatment prevented a rise in ROS when ethanol was added at the 
end of the pre-treatment period.   The time required for ipsapirone to block the ethanol-
associated increase in ROS suggests the possibility that ipsapirone’s effects involved the 
upregulation of one or more genes that encode proteins that prevent an increase in ROS.  
 
Effects of Ipsapirone on the Expression of Endogenous Antioxidants 
An intriguing finding in the catalase studies was that there was a main effect of 
ipsapirone after 8 hours of treatment in our studies of catalase expression.  At this early 
time point, there was an ethanol-induced increase of catalase.  The ethanol-mediated 
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increase in catalase was followed by an increased in catalase activity.  However, 
ipsapirone treatment blocked both the rise in expression and activity of this enzyme.  
Because catalase is both an antioxidant enzyme and the major brain enzymes to 
metabolize ethanol (Zimatkin et al., 2006), it is not clear whether one or both functions 
were altered by this change.  If the increased levels of catalase augmented ethanol 
metabolism and production of neurotoxic acetaldehyde (Lee et al., 2005) at this early 
time point, the ipsapirone-mediated blockade of this ethanol effect could help reduce the 
damaging effects of ethanol.  Certainly, these results suggest a possible role of ipsapirone 
in mediating the regulation of catalase expression.  However, we must also consider the 
possibility that ipsapirone’s effects on catalase prevented the cell from detoxifying 
elevated levels of ROS and led to damaging effects on the cell.  As noted, it is essential 
for the cell to maintain ROS levels in a range that promote its health and to activate NF-
κB dependent survival pathways (Lupertz et al., 2008).  However, in light of ipsapirone’s 
neuroprotective effects against ethanol-associated apoptosis, the latter scenario does not 
appear to be dominant.   
 At later critical time points, ipsapirone exerted potentially neuroprotective effects 
on ethanol-treated neurons.  Co-treatment with ipsapirone upregulated catalase 
expression at 24 hours and catalase activity at 48 hours.  The ipsapirone-mediated 
elevation of catalase at 24 hours and catalase activity at 48 hours could contribute to the 
neuroprotective effects that are observed when ipsapirone is co-administered with ethanol 
on a more prolonged basis (> 24 hours).  For example, the catalase changes might 
contribute to ipsapirone-mediated neuroprotection found in vivo when ethanol-treated 
pregnant dams are treated with this or a related drug during the latter portion of gestation 
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(Tajuddin and Druse, 1999; Tajuddin and Druse, 2001).  These effects could be important 
to the developing rat brain, where catalase is an important antioxidant to counter the 
effects of oxidative stress.  In fact, the activity of catalase in the developing brain is 550% 
compared to adult brain (Bayir et al., 2006). 
Although the ipsapirone-mediated elevation of catalase activity at 48 hours does 
not explain ipsapirone’s anti-apoptotic effects at 24 hours, this change could contribute to 
the neuroprotective effects that are observed when ipsapirone is co-administered with 
ethanol on a more prolonged basis (> 24 hours).  For example, the catalase changes might 
contribute to ipsapirone-mediated neuroprotection found in vivo when ethanol-treated 
pregnant dams are treated with this or a related drug during the latter portion of gestation 
(Tajuddin and Druse, 1999; Tajuddin and Druse, 2001). 
It has been shown in many different studies that enhancing the expression of SOD 
and catalase provide protection against cell death (Dasgupta et al., 2006; Guo et al., 2001; 
Thiruchelvam et al., 2005; Wheeler et al., 2001).  The present study demonstrated that the 
SOD/catalase mimetic EUK-134 protected developing neurons from ethanol-induced 
apoptosis.  However, when expression of antioxidant enzymes is excessive, as in the 
over-expresssion of these genes, it could have an adverse outcome (Brown et al., 1999; 
Larosche et al., 2009; Zemlyak et al., 2006).  Perhaps such adverse effects occur when 
excessive activity of one antioxidant enzyme could over-produce a reactive intermediate, 
which would upset the balance in the cell and lead to cell death [reviewed in (Halliwell, 
2000). 
In summary, it appears likely that the neuroprotective effects of ipsapirone 
involve, in part, its ability to modulate the expression of genes encoding antioxidant 
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enzymes.  Certainly, these studies showed that both ethanol and ipsapirone modulate the 
expression of genes that encode antioxidant enzymes and that some of these changes are 
paralleled or followed by corresponding alterations in enzyme activity.  Although some 
ipsapirone mediated changes have the potential to lead to an unfavorable balance of ROS 
or augmented formation of a neurotoxic agent, the evidence that ipsapirone provides 
neuroprotection against ethanol-induced apoptosis strongly argues against that 
possibility.  Moreover, these studies showed that a mimetic of catalase and SOD exerts 
neuroprotection against ethanol-associated apoptosis.  And finally, pre-treatment of 
neuronal cultures with ipsapirone attenuates the ethanol-associated rise in ROS.  
Therefore, these studies provide additional evidence that a 5-HT1A agonist such as 
ipsapirone might provide protection against fetal alcohol damage to developing 5-HT and 
other CNS neurons.
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Table 3.  Summary of Data 
Time   Treatments SOD1 SOD2 SOD activity Catalase 
Catalase 
activity 
Ipsapirone + + + N/C 
Ethanol N/C ++ N/C N/C 
2 
Hour 
E+I - + N/C N/C 
Not  
measured 
Ipsapirone N/C N/C N/C N/C 
Ethanol N/C N/C N/C N/C 
4 
Hour 
E+I N/C N/C N/C N/C 
Not  
measured 
Ipsapirone N/C 
Ethanol N/C 
6 
Hour 
E+I 
Not  
measured 
Not  
measured 
N/C 
Not  
measured 
Not  
measured 
Ipsapirone N/C 
Ethanol + 
8 
Hour 
E+I 
Not  
measured 
Not  
measured 
Not  
measured 
N/C 
Not  
measured 
Ipsapirone N/C N/C N/C 
Ethanol N/C N/C N/C 
12 
Hour 
E+I N/C N/C 
Not  
measured 
N/C 
Not  
measured 
Ipsapirone N/C 
Ethanol + 
18 
Hour 
E+I 
Not  
measured 
Not  
measured 
Not  
measured 
Not  
measured 
N/C 
Ipsapirone N/C N/C N/C ++ N/C 
Ethanol ++ + N/C  N/C 
24 
Hour 
E+I ++ + N/C + N/C 
Ipsapirone N/C N/C N/C N/C 
Ethanol N/C N/C N/C N/C 
48 
Hour 
E+I -- + - 
Not  
measured 
+ 
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